<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery - Sanders, RD - 2013 | Cochrane Library</title> <meta content="Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery - Sanders, RD - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009971.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery - Sanders, RD - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009971.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009971.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery" name="citation_title"/> <meta content="Robert D Sanders" name="citation_author"/> <meta content="University College London Hospital &amp; Wellcome Department of Imaging Neuroscience, University College London" name="citation_author_institution"/> <meta content="Amanda Nicholson" name="citation_author"/> <meta content="University of Liverpool" name="citation_author_institution"/> <meta content="Sharon R Lewis" name="citation_author"/> <meta content="Royal Lancaster Infirmary" name="citation_author_institution"/> <meta content="Sharon.Lewis@mbht.nhs.uk" name="citation_author_email"/> <meta content="Andrew F Smith" name="citation_author"/> <meta content="Royal Lancaster Infirmary" name="citation_author_institution"/> <meta content="Phil Alderson" name="citation_author"/> <meta content="National Institute for Health and Care Excellence" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD009971.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/07/03" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009971.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009971.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009971.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Angioplasty; Atherosclerosis [complications, *drug therapy]; Atorvastatin; Cardiovascular Diseases [mortality, *prevention &amp; control]; Cause of Death; Cholestyramine Resin [therapeutic use]; Heptanoic Acids [therapeutic use]; Hydroxymethylglutaryl‐CoA Reductase Inhibitors [*therapeutic use]; Lovastatin [therapeutic use]; Perioperative Care [methods]; Postoperative Complications [mortality, *prevention &amp; control]; Pyrroles [therapeutic use]; Randomized Controlled Trials as Topic; Sitosterols [therapeutic use]; Vascular Surgical Procedures [*adverse effects, mortality]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009971.pub2&amp;doi=10.1002/14651858.CD009971.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="uQyIsxpV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009971\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009971\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009971.pub2",title:"Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery",firstPublishedDate:"Jul 3, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Anaesthesia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009971.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009971.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009971.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009971.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009971.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009971.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009971.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009971.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009971.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009971.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1230 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009971.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-sec-0071"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-sec-0046"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-sec-0065"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/appendices#CD009971-sec-0076"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/table_n/CD009971StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/table_n/CD009971StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/information#CD009971-cr-0002">Robert D Sanders</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/information#CD009971-cr-0003">Amanda Nicholson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/information#CD009971-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Sharon R Lewis</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/information#CD009971-cr-0005">Andrew F Smith</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009971.pub2/information#CD009971-cr-0006">Phil Alderson</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/information/en#CD009971-sec-0102">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 03 July 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009971.pub2">https://doi.org/10.1002/14651858.CD009971.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009971-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009971-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009971-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009971-abs-0005">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009971-abs-0001" lang="en"> <section id="CD009971-sec-0001"> <h3 class="title" id="CD009971-sec-0001">Background</h3> <p>Patients undergoing vascular surgery are a high‐risk population with widespread atherosclerosis, an adverse cardiovascular risk profile and often multiple co‐morbidities. Postoperative cardiovascular complications, including myocardial infarct (MI), are common. Statins are the medical treatment of choice to reduce high cholesterol levels. Evidence is accumulating that patients taking statins at the time of surgery are protected against a range of perioperative complications, but the specific benefits for patients undergoing noncardiac vascular surgery are not clear. </p> </section> <section id="CD009971-sec-0002"> <h3 class="title" id="CD009971-sec-0002">Objectives</h3> <p>We examined whether short‐term statin therapy, commenced before or on the day of noncardiac vascular surgery and continuing for at least 48 hours afterwards, improves patient outcomes including the risk of complications, pain, quality of life and length of hospital stay<i>.</i> We also examined whether the effect of statin therapy on these outcomes changes depending on the dose of statin received. </p> </section> <section id="CD009971-sec-0003"> <h3 class="title" id="CD009971-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2012, Issue 7), MEDLINE via Ovid SP (1966 to August 2012), EMBASE via Ovid SP (1966 to August 2012), CINAHL via EBSCO host (1966 to August 2012) and ISI Web of Science (1946 to July 2012) without any language restriction. We used a combination of free text search and controlled vocabulary search. The results were limited to randomized controlled clinical trials (RCTs). We conducted forwards and backwards citation of key articles and searched two clinical trial Websites for ongoing trials (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>  and <a href="http://www.controlled-trials.com" target="_blank">http://www.controlled‐trials.com</a>). </p> </section> <section id="CD009971-sec-0004"> <h3 class="title" id="CD009971-sec-0004">Selection criteria</h3> <p>We included RCTs that had compared short‐term statin therapy, either commenced de novo or with existing users randomly assigned to different dosages, in adult participants undergoing elective and emergency noncardiac arterial surgery, including both open and endovascular procedures. We defined <i>short‐term</i> as commencing before or on the day of surgery and continuing for at least 48 hours afterwards<b>.</b> </p> </section> <section id="CD009971-sec-0005"> <h3 class="title" id="CD009971-sec-0005">Data collection and analysis</h3> <p>Two authors independently assessed trial quality and extracted data, including information on adverse events. We contacted study authors for additional information. We performed separate analyses for the comparisons of statin with placebo/no treatment and between different doses of statin. We presented results as pooled risk ratios (RRs) with 95% confidence intervals (CIs) based on random‐effects models (inverse variance method). We employed the Chi<sup>2</sup> test and calculated the I<sup>2</sup> statistic to investigate study heterogeneity. </p> </section> <section id="CD009971-sec-0006"> <h3 class="title" id="CD009971-sec-0006">Main results</h3> <p>We identified six eligible studies in total. The six Included studies were generally of high quality, but the largest eligible study was excluded because of concerns about its validity. Study populations were statin naive, which led to a considerable loss of eligible participants. </p> <p>Five RCTs compared statin use with placebo or standard care. We pooled results from three studies, with a total of 178 participants, for mortality and non‐fatal event outcomes. In the statin group, 7/105 (6.7%) participants died within 30 days of surgery, as did 10/73 (13.7%) participants in the control group. Only one death in each group was from cardiovascular causes, with an incidence of 0.95% in statin participants and 1.4% in control participants, respectively. All deaths occurred in a single study population, and so effect estimates were derived from one study only. The risk ratio (RR) of all‐cause mortality in statin users showed a non‐significant decrease in risk (RR 0.73, 95% CI 0.31 to 1.75). For cardiovascular death, the risk ratio was 1.05 (95% CI 0.07 to 16.20). Non‐fatal MI within 30 days of surgery was reported in three studies and occurred in 4/105 (3.8%) participants in the statin group and 8/73 (11.0%) participants receiving placebo, for a non‐significant decrease in risk (RR 0.47, 95% CI 0.15 to 1.52). Several studies reported muscle enzyme levels as safety measures, but only three (with a total of 188 participants) reported explicitly on clinical muscle syndromes, with seven events reported and no significant difference found between statin users and controls (RR 0.94, 95% CI 0.24 to 3.63). The only participant‐reported outcome was nausea in one small study,with no significant difference in risk between groups. </p> <p>Two studies compared different doses of atorvastatin, with a total of 145 participants, but reported data were not sufficient to allow us to determine the effect of higher doses on any outcome. </p> </section> <section id="CD009971-sec-0007"> <h3 class="title" id="CD009971-sec-0007">Authors' conclusions</h3> <p>Evidence was insufficient to allow review authors to conclude that statin use resulted in either a reduction or an increase in any of the outcomes examined. The existing body of evidence leaves questions about the benefits of perioperative use of statins for vascular surgery unanswered. Widespread use of statins in the target population means that it may now be difficult for researchers to undertake the large RCTs needed to demonstrate any effect on the incidence of postoperative cardiovascular events. However, participant‐reported outcomes have been neglected and warrant further study. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009971-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009971-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009971-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009971-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009971-abs-0002" lang="en"> <h3>Perioperative statin use to improve outcomes during and after noncardiac vascular surgery </h3> <p>Patients undergoing vascular surgery often have widespread atherosclerosis and are at high risk of complications during and after the operation. (Atherosclerosis is a condition in which an artery wall thickens as the result of an accumulation of fatty deposits such as cholesterol.) Statins are widely used to treat raised cholesterol levels but also confer beneficial effects on the inflammatory and circulatory systems. Their long‐term use in patients with vascular disease is well established. Accumulating evidence suggests that short‐term treatment with statins may reduce complications after cardiac surgery, but it is not yet clear whether there are any benefits for vascular surgery patients.    </p> <p>In July 2012 we searched medical databases for controlled trials of participants who had undergone aortic or arterial surgery and were randomly assigned to either statins or placebo (or standard care). Many vascular surgery patients are already taking statins; therefore we also included trials that randomly assigned participants to different doses of statin. Statin treatment should have been started any time between the decision to operate and performance of the operation and continued for at least 48 hours after the operation. We wanted to investigate the effect of this short‐term statin therapy on the risk of death and cardiovascular events such as heart attack and stroke within 30 days of surgery. We also considered adverse effects of statins such as muscle pain. </p> <p>We found five studies that compared participants receiving statins with a control treatment or with placebo, but only three of these reported outcomes could be combined in the meta‐analyses. These three studies were of high quality but studied only 178 participants in total. This means that evidence was insufficient to allow review authors to determine whether statins improved patient outcomes after surgery. We were also not able to establish whether any adverse effects such as muscle pain were associated with statin use. </p> <p>We found that two studies had compared different doses of atorvastatin, but evidence was insufficient to determine whether any benefits or risks were associated with using a higher dose.   </p> <p>Given the limited quantity of data obtained from randomized controlled trials, further studies are required to allow investigators to gather better information about whether prescribing statins around the time of vascular surgery can improve outcomes. However, widespread use of statins in patients before they need surgery may make these studies impracticable. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009971-sec-0071" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009971-sec-0071"></div> <h3 class="title" id="CD009971-sec-0072">Implications for practice</h3> <section id="CD009971-sec-0072"> <p>Evidence is insufficient to allow review authors to conclude that perioperative statin use in patients not already receiving statins reduces or increases the risk of complications following noncardiac vascular surgery. We are also unable to comment on the safety of statins around the time of surgery. </p> </section> <h3 class="title" id="CD009971-sec-0073">Implications for research</h3> <section id="CD009971-sec-0073"> <p>The existing body of evidence leaves unanswered questions about the benefits of perioperative use of statins for vascular surgery. The study populations were statin‐naive, which led to large loss of eligible participants, as many patients were already receiving statins. With the more widespread use of statins, it may now be difficult to undertake the large RCTs needed to demonstrate any effect on rare events such as mortality in a statin‐naive population. Future trials could focus on the impact of different dosages in patients already taking statins. It is important to understand the patient's view and to include more patient‐reported outcomes<b><i>.</i> </b> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009971-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009971-sec-0015"></div> <div class="table" id="CD009971-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Perioperative statins versus placebo or no treatment for improving outcomes during and after noncardiac vascular surgery</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Perioperative statins versus placebo or no treatment for improving outcomes during and after noncardiac vascular surgery</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> participants with improving outcomes during and after noncardiac vascular surgery.<br/> <b>Settings:</b> hospital.<br/> <b>Intervention:</b> perioperative statins versus placebo or no treatment. </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Perioperative statins versus placebo or no treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b> <br/> Follow‐up: 30 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.73</b> <br/> (0.31 to 1.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>178<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Effect estimate based on 1 study only.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> <br/> (12 to 70) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Death from cardiovascular causes</b> <br/> Follow‐up: 30 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.05</b> <br/> (0.07 to 16.2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>178<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Effect estimate based on 2 events occurring in 1 study.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b> <br/> (2 to 486) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Myocardial infarction (non‐fatal)</b> <br/> Follow‐up: 30 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.47</b> <br/> (0.15 to 1.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>178<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> <br/> (6 to 61) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Stroke/TIA (non‐fatal)</b> <br/> Follow‐up: 30 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.24</b> <br/> (0.03 to 2.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>178<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Two events only across 3 studies.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>2 per 1000</b> <br/> (0 to 22) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported outcomes</b>－not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 study measured or reported any participant‐reported outcomes (nausea in STAR VaS). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse muscle effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>188<br/> (3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to pool. Important differences in assessment of endpoint between studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence:<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect;<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate;<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate; and<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Based on observational data reported by <a href="./references#CD009971-bbs2-0062" title="NowygrodR , EgorovaN , GrecoG , AndersonP , GelijnsA , MoskowitzA , et al. Trends, complications, and mortality in peripheral vascular surgery. Journal of Vascular Surgery2006; Vol. 43, issue 2:205‐16. [PUBMED: 16476588] ">Nowygrod 2006</a> and <a href="./references#CD009971-bbs2-0054" title="LeManachY , Ibanez EstevesC , BertrandM , GoarinJP , FleronMH , CoriatP , et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery. Anesthesiology2011; Vol. 114, issue 1:98‐104. [PUBMED: 21178671] ">Le Manach 2011</a>.<br/> <sup>2</sup> Confidence interval crosses no effect and is consistent with increased and decreased risks.<br/> <sup>3</sup> Effect estimate from 1 study and/or based on fewer then 5 events. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009971-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009971-sec-0016"></div> <section id="CD009971-sec-0017"> <h3 class="title" id="CD009971-sec-0017">Description of the condition</h3> <p>Atherosclerosis can affect any major artery in the body, and the clinical consequences depend on the site of atheromatous plaque obstruction. Narrowing or stenosis due to atheroma in the lower limbs or in the abdominal aorta may lead to ischaemia (reduced blood supply) to leg muscles, resulting in muscle pain while walking (claudication). Reduced blood supply to the skin and underlying tissues causes ischaemia, ulceration and ultimately gangrene. Weakening of the arterial wall in the aorta may lead to dilation of the artery and aneurysm formation with risk of rupture. In the carotid arteries, fragments from a plaque (emboli) may cause a stroke or a transient ischaemic attack (TIA). Noncardiac vascular surgical procedures aim to clear, replace or bypass diseased arteries through open surgical dissection or, increasingly, by endovascular approaches. Amputation may be necessary if the circulation cannot be restored to a limb. Using the US National Inpatient Sample from 2003, Nowygrod et al reported 37,726 abdominal aortic aneurysm (AAA) repairs, 139,083 carotid artery revascularizations, 137,019 lower extremity revascularizations and 115,749 amputations (<a href="./references#CD009971-bbs2-0062" title="NowygrodR , EgorovaN , GrecoG , AndersonP , GelijnsA , MoskowitzA , et al. Trends, complications, and mortality in peripheral vascular surgery. Journal of Vascular Surgery2006; Vol. 43, issue 2:205‐16. [PUBMED: 16476588] ">Nowygrod 2006</a>). Data from the UK suggest 3000 to 4000 AAA repairs per year and a similar number of carotid endarterectomies (<a href="./references#CD009971-bbs2-0066" title="SandersRD , BottleA , JamesonSS , MozidA , AylinP , EdgerL , et al. Independent preoperative predictors of outcomes in orthopedic and vascular surgery: the influence of time interval between an acute coronary syndrome or stroke and the operation. Annals of Surgery2012; Vol. 255, issue 5:901‐7. [PUBMED: 22504189] ">Sanders 2012</a>; <a href="./references#CD009971-bbs2-0072" title="VASGBI. The Vascular Society of Great Britain and Ireland. Lees T, Stansby G (editors).The National Vascular Database Report 2009. http://www.vasgbi.com/. ">VASGBI 2009</a>). </p> <p>Patients undergoing these vascular procedures constitute a high‐risk population, with widespread atherosclerosis, an adverse cardiovascular risk profile and often multiple co‐morbidities. The nature of vascular surgery in this population entails a high risk of perioperative complications and mortality. For example, bleeding is the most common perioperative complication, particularly in open procedures. US data indicate that 17.1% of AAA open repairs and 11% of open lower extremity revascularizations were complicated by bleeding (<a href="./references#CD009971-bbs2-0062" title="NowygrodR , EgorovaN , GrecoG , AndersonP , GelijnsA , MoskowitzA , et al. Trends, complications, and mortality in peripheral vascular surgery. Journal of Vascular Surgery2006; Vol. 43, issue 2:205‐16. [PUBMED: 16476588] ">Nowygrod 2006</a>). Cardiac complications are frequent, estimated at 8% in open AAA and 2% to 3% in open carotid and lower extremity procedures (<a href="./references#CD009971-bbs2-0062" title="NowygrodR , EgorovaN , GrecoG , AndersonP , GelijnsA , MoskowitzA , et al. Trends, complications, and mortality in peripheral vascular surgery. Journal of Vascular Surgery2006; Vol. 43, issue 2:205‐16. [PUBMED: 16476588] ">Nowygrod 2006</a>) and are the primary cause of death in the perioperative period (<a href="./references#CD009971-bbs2-0055" title="LeeTH , MarcantonioER , MangioneCM , ThomasEJ , PolanczykCA , CookEF , et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation1999; Vol. 100, issue 10:1043‐9. [PUBMED: 10477528] ">Lee 1999</a>; <a href="./references#CD009971-bbs2-0052" title="LeManachY , PerelA , CoriatP , GodetG , BertrandM , RiouB . Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology2005; Vol. 102, issue 5:885‐91. [PUBMED: 15851872] ">Le Manach 2005</a>; <a href="./references#CD009971-bbs2-0054" title="LeManachY , Ibanez EstevesC , BertrandM , GoarinJP , FleronMH , CoriatP , et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery. Anesthesiology2011; Vol. 114, issue 1:98‐104. [PUBMED: 21178671] ">Le Manach 2011</a>). Postoperative myocardial infarcts (PMI) can be difficult to diagnose, and the widely used universal definition of a myocardial infarct (<a href="./references#CD009971-bbs2-0070" title="ThygesenK , AlpertJS , WhiteHD . Universal definition of myocardial infarction. Journal of the American College of Cardiology2007; Vol. 50, issue 22:2173‐95. [PUBMED: 18036459] ">Thygesen 2007</a>) may not allow detection of all cases (<a href="./references#CD009971-bbs2-0054" title="LeManachY , Ibanez EstevesC , BertrandM , GoarinJP , FleronMH , CoriatP , et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery. Anesthesiology2011; Vol. 114, issue 1:98‐104. [PUBMED: 21178671] ">Le Manach 2011</a>). Other investigators found evidence of  perioperative myocardial infarction in 24% of 447 vascular surgery participants (<a href="./references#CD009971-bbs2-0050" title="LandesbergG , ShatzV , AkopnikI , WolfYG , MayerM , BerlatzkyY , et al. Association of cardiac troponin, CK‐MB, and postoperative myocardial ischemia with long‐term survival after major vascular surgery. Journal of the American College of Cardiology2003; Vol. 42, issue 9:1547‐54. [PUBMED: 14607436] ">Landesberg 2003</a>). </p> <p>The mechanisms underlying these complications are not fully understood. Stress responses, inflammatory processes and endothelial dysfunction are increased during surgery. Bleeding is known to be an important risk for cardiac events and perioperative mortality, probably acting through effects on oxygen delivery, haemodynamics, sympathetic stress and inflammation and coagulation (<a href="./references#CD009971-bbs2-0052" title="LeManachY , PerelA , CoriatP , GodetG , BertrandM , RiouB . Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology2005; Vol. 102, issue 5:885‐91. [PUBMED: 15851872] ">Le Manach 2005</a>). For ischaemic events, the relative importance of plaque rupture or embolism and disturbances in blood flow leading to a dynamic mismatch between oxygen supply and demand (<a href="./references#CD009971-bbs2-0065" title="SandersRD , DegosV , YoungWL . Cerebral perfusion under pressure: is the autoregulatory 'plateau' a level playing field for all?. Anaesthesia2011; Vol. 66, issue 11:968‐72. [PUBMED: 21933160] ">Sanders 2011</a>) is unclear. The perioperative period constitutes a high‐risk time for patients undergoing vascular surgery, and optimization strategies to reduce this risk are required. </p> </section> <section id="CD009971-sec-0018"> <h3 class="title" id="CD009971-sec-0018">Description of the intervention</h3> <p>Statins are the medical treatment of choice for reducing high cholesterol levels. They inhibit 3‐hydroxy‐3‐methyl‐glutaryl (HMG)‐CoA reductase, the rate limiting step in cholesterol synthesis, which leads to upregulation of hepatic low‐density lipoprotein (LDL) receptors and reduction in circulating LDL and very low‐density lipoprotein (VLDL) levels. Meta‐analyses have demonstrated that statins reduce the risk of fatal and non‐fatal cardiac events in the community, both in healthy populations and in those with existing cardiac disease (<a href="./references#CD009971-bbs2-0058" title="MillsEJ , WUP , ChongG , GhementI , SinghS , AklEA , et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta‐analysis of 170 255 patients from 76 randomized trials. QJM2011; Vol. 104, issue 2:109‐24. [PUBMED: 20934984] ">Mills 2011</a>; <a href="./references#CD009971-bbs2-0069" title="TaylorF , WardK , MooreTHM , BurkeM , Davey SmithG , CasasJP , et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD004816.pub4] ">Taylor 2011</a>) These meta‐analyses found no evidence for increased risk of rhabdomyolysis or other clinical muscle syndromes in statin users, but there was evidence of increased levels of muscle enzymes (<a href="./references#CD009971-bbs2-0058" title="MillsEJ , WUP , ChongG , GhementI , SinghS , AklEA , et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta‐analysis of 170 255 patients from 76 randomized trials. QJM2011; Vol. 104, issue 2:109‐24. [PUBMED: 20934984] ">Mills 2011</a>) </p> <p>Evidence is accumulating that patients taking statins at the time of surgery are protected against a diverse range of perioperative complications, including myocardial infarction, renal failure, delirium and death (<a href="./references#CD009971-bbs2-0049" title="KatznelsonR , DjaianiGN , BorgerMA , FriedmanZ , AbbeySE , FedorkoL , et al. Preoperative use of statins is associated with reduced early delirium rates after cardiac surgery. Anesthesiology2009; Vol. 110, issue 1:67‐73. [PUBMED: 19104172] ">Katznelson 2009</a>; <a href="./references#CD009971-bbs2-0053" title="LeManachY , GodetG , CoriatP , MartinonC , BertrandM , FleronMH , et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesthesia and Analgesia2007; Vol. 104, issue 6:1326‐33. [PUBMED: 17513620] ">Le Manach 2007</a>; <a href="./references#CD009971-bbs2-0054" title="LeManachY , Ibanez EstevesC , BertrandM , GoarinJP , FleronMH , CoriatP , et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery. Anesthesiology2011; Vol. 114, issue 1:98‐104. [PUBMED: 21178671] ">Le Manach 2011</a>; <a href="./references#CD009971-bbs2-0059" title="MolnarAO , CocaSG , DevereauxPJ , JainAK , KitchluA , LuoJ , et al. Statin use associates with a lower incidence of acute kidney injury after major elective surgery. Journal of the American Society of Nephrology2011; Vol. 22, issue 5:939‐46. [PUBMED: 21493769] ">Molnar 2011</a>; <a href="./references#CD009971-bbs2-0061" title="NoordzijPG , PoldermansD , SchoutenO , SchreinerF , FeringaHH , DunkelgrunM , et al. Beta‐blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery. Coronary Artery Disease2007;18(1):67‐72. [PUBMED: 17172933] ">Noordzij 2007</a>). Systematic reviews of observational studies and randomized controlled trials (RCTs) have indicated that statin users have reduced postoperative cardiac complications compared with participants naive to statins, but the evidence base is weak, particularly for noncardiac surgery (<a href="./references#CD009971-bbs2-0039" title="ChopraV , WesorickDH , SussmanJB , GreeneT , RogersM , FroehlichJB , et al. Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta‐analysis. Archives of Surgery2012; Vol. 147, issue 2:181‐9. [PUBMED: 22351917] ">Chopra 2012</a>; <a href="./references#CD009971-bbs2-0048" title="KapoorAS , KanjiH , BuckinghamJ , DevereauxPJ , McAlisterFA . Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ2006; Vol. 333, issue 7579:1149. [PUBMED: 17088313] ">Kapoor 2006</a>; <a href="./references#CD009971-bbs2-0074" title="WinchesterDE , WenX , XieL , BavryAA . Evidence of pre‐procedural statin therapy a meta‐analysis of randomized trials. Journal of the American College of Cardiology2010; Vol. 56, issue 14:1099‐109. [PUBMED: 20825761] ">Winchester 2010</a>). </p> </section> <section id="CD009971-sec-0019"> <h3 class="title" id="CD009971-sec-0019">How the intervention might work</h3> <p>The lipid‐lowering action of statins is likely to be the primary mechanism involved in preventing the development of cardiovascular disease. However, it is unlikely to be the sole mechanism of protection in the perioperative period as the time scale is too short for any alteration in lipid levels to be meaningful. There is good evidence that statins also have pleiotropic effects that could feasibly influence perioperative outcomes. These include an anti‐inflammatory action, improvement in endothelial function, reduction of oxidative stress, improved organ autoregulation of blood flow, stabilization of atheromatous plaques and inhibition of platelet aggregation (<a href="./references#CD009971-bbs2-0073" title="WangCY , LiuPY , LiaoJK . Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends in Molecular Medicine2008; Vol. 14, issue 1:37‐44. [PUBMED: 18068482] ">Wang 2008</a>). Although the molecular mechanisms of different effects need to be unravelled, effects on endothelial nitric oxide may be pivotal. </p> </section> <section id="CD009971-sec-0020"> <h3 class="title" id="CD009971-sec-0020">Why it is important to do this review</h3> <p>Many existing studies and one ongoing Cochrane reviews (<a href="./references#CD009971-bbs2-0056" title="LiakopoulosOJ , KuhnEW , SlottoschI , WassmerG , WahlersT . Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database of Systematic Reviews2012, Issue 4. [DOI: 10.1002/14651858.CD008493.pub2] ">Liakopoulos 2010</a>;) have focused on perioperative statin use in cardiac surgery to improve outcomes. However, patients undergoing vascular surgery have a particularly high risk of coronary artery disease, and cardiac events are a common postoperative complication in this population. Two existing non‐Cochrane reviews on perioperative statin use have drawn on a range of study designs to examine participants undergoing various surgical and invasive procedures and include two RCTs on participants undergoing vascular surgery (<a href="./references#CD009971-bbs2-0048" title="KapoorAS , KanjiH , BuckinghamJ , DevereauxPJ , McAlisterFA . Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ2006; Vol. 333, issue 7579:1149. [PUBMED: 17088313] ">Kapoor 2006</a>; <a href="./references#CD009971-bbs2-0074" title="WinchesterDE , WenX , XieL , BavryAA . Evidence of pre‐procedural statin therapy a meta‐analysis of randomized trials. Journal of the American College of Cardiology2010; Vol. 56, issue 14:1099‐109. [PUBMED: 20825761] ">Winchester 2010</a>). A more recent review adds an extra trial and assessment of risk of bias, but does not present results separately for participants undergoing noncardiac vascular surgery. (<a href="./references#CD009971-bbs2-0039" title="ChopraV , WesorickDH , SussmanJB , GreeneT , RogersM , FroehlichJB , et al. Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta‐analysis. Archives of Surgery2012; Vol. 147, issue 2:181‐9. [PUBMED: 22351917] ">Chopra 2012</a>). Our review will focus only on trials of participants undergoing vascular surgery; it will include a risk of bias assessment of included studies and will consider outcomes other than cardiovascular events. Our search strategy will include EMBASE, which provides in‐depth drug indexing. </p> <p>To establish how widely statins should be used in clinical practice, it is important to examine whether statins reduce postoperative morbidity and mortality for procedures other than cardiac surgery. . A systematic review is required to confirm any effect, to estimate effect size and to provide guidance on perioperative use of statins both in clinical trials and in day‐to‐day practice. Guidelines would indicate that many patients with vascular disease should be receiving statins routinely (<a href="./references#CD009971-bbs2-0060" title="NICE . Statins for the prevention of cardiovascular events. National Institute for Health and Clinical Excellence. Technology Appraisal2006; Vol. 94. ">NICE 2006</a>); however, observational reports indicate that this is often not achieved in practice. In the US, one study found that only 61% of participants undergoing major reconstructive vascular surgery were receiving statins at the time of initial surgical evaluation (<a href="./references#CD009971-bbs2-0057" title="MarshallC , LinPH , HuynhTT , KougiasP . How optimal is the medical management of patients prior to major reconstructive vascular surgery? The results of a cross‐sectional study. Vascular and Endovascular Surgery2009; Vol. 43, issue 3:238‐43. [PUBMED: 19190039] ">Marshall 2009</a>). Only 57% of participants undergoing vascular surgery in the UK were receiving statins (<a href="./references#CD009971-bbs2-0072" title="VASGBI. The Vascular Society of Great Britain and Ireland. Lees T, Stansby G (editors).The National Vascular Database Report 2009. http://www.vasgbi.com/. ">VASGBI 2009</a>). Estimates of the proportion of patients with peripheral vascular disease who are receiving statins have increased from 43.3% in Canada and 56% in the Netherlands in 2004 (<a href="./references#CD009971-bbs2-0034" title="Al‐OmranM , MamdaniMM , LindsayTF , MeloM , JuurlinkDN , VermaS . Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population‐based study. Journal of Vascular Surgery2008; Vol. 48, issue 3:607‐12. [PUBMED: 18585886] ">Al‐Omran 2008</a>; <a href="./references#CD009971-bbs2-0047" title="HoeksSE , Scholte Op ReimerWJ , SchoutenO , LenzenMJ , vanUrkH , PoldermansD . Statin use in the elderly: results from a peripheral vascular survey in The Netherlands. Journal of Vascular Surgery2008; Vol. 48, issue 4:891‐5; discussion 895‐6. [PUBMED: 18992415] ">Hoeks 2008</a>) to 84% in Ireland in 2009 (<a href="./references#CD009971-bbs2-0040" title="CoveneyAP , O'BrienGC , FultonGJ . ACE up the sleeve－are vascular patients medically optimized?. Journal of Vascular Health and Risk Management2011; Vol. 7:15‐21. [PUBMED: 21339909] ">Coveney 2011</a>). Demonstration of a robust beneficial effect around the time of surgery not only might improve perioperative outcomes but also may lead to longer‐term prescribing. </p> <p>Evidence suggests a dose‐response effect for statins in primary prevention (<a href="./references#CD009971-bbs2-0051" title="LawMR , WaldNJ , RudnickaAR . Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta‐analysis. BMJ2003; Vol. 326, issue 7404:1423. [PUBMED: 12829554] ">Law 2003</a>), with higher doses leading to greater risk reduction. Fewer data are available for a dose‐response relationship in secondary prevention, with some studies describing an effect of duration but not of dosage (<a href="./references#CD009971-bbs2-0038" title="ChenWT , KrishnanGM , SoodN , KlugerJ , ColemanCI . Effect of statins on atrial fibrillation after cardiac surgery: a duration‐ and dose‐response meta‐analysis. Journal of Thoracic and Cardiovascular Surgery2010; Vol. 140, issue 2:364‐72. [PUBMED: 20381820] ">Chen 2010</a>). Our review also considered whether any beneficial effect of statins given at the time of surgery is dependent on the dose or duration of statin received. </p> <p>We anticipated that the evidence base for trials of statin use in vascular surgery could be small. By considering a range of outcomes, including functional measures, we aimed to clarify the endpoints for which evidence of a beneficial or adverse effect has been found and those for which evidence is insufficient to allow researchers to reach a conclusion. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009971-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009971-sec-0021"></div> <p>We examined whether short‐term statin therapy, commenced  before or on the day of noncardiac vascular surgery and continuing for at least 48 hours afterwards, improves patient outcomes including risk of complications, pain, quality of life and length of hospital stay<i>.</i> We also examined whether the effect of statin therapy on these outcomes changes depending on the dose of statin received. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009971-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009971-sec-0022"></div> <section id="CD009971-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009971-sec-0024"> <h4 class="title">Types of studies</h4> <p>We considered all randomized controlled trials (RCTs) including quasi‐randomized and cluster‐randomized trials. </p> </section> <section id="CD009971-sec-0025"> <h4 class="title">Types of participants</h4> <p>We included all adult participants (older than 18 years of age) who were scheduled for elective and emergency noncardiac arterial vascular surgery, including both open and endovascular procedures. We included participants scheduled for aortic, iliac, peripheral revascularization and carotid procedures. We also included participants scheduled for amputation as the result of complications of the vascular system.  </p> <p>We excluded participants requiring cardiopulmonary bypass.</p> <p>We included in the review studies restricted to older participants, such as those older than 50 years of age. We also included trials with a wider study population of surgical participants, for instance also including participants undergoing cardiac procedures, provided the noncardiovascular participants were in the majority, or the results are presented separately for this group. </p> </section> <section id="CD009971-sec-0026"> <h4 class="title">Types of interventions</h4> <p>We considered studies that have prescribed statins of any commercially available type at the time of the study, at any dose, either commenced de novo or with existing users randomly assigned to different dosages. We defined <i>short‐term</i> as commencing before or on the day of surgery and continuing for at least 48 hours afterwards. </p> <p>Comparison groups were one of:</p> <p> <ul id="CD009971-list-0001"> <li> <p>Placebo; or</p> </li> </ul> <ul id="CD009971-list-0002"> <li> <p>No treatment or standard care.</p> </li> </ul> </p> <p>We anticipated that most trials will be restricted to statin‐naive populations, that is, participants who were not taking statins before surgery was scheduled. Many patients with vascular disease will already be on statins in line with current clinical guidelines and will be ineligible for these trials. We therefore, aimed to include any trials that recruited patients already receiving statin therapy but that randomly assigned them to a higher dose. In this patient group, the comparison group was: </p> <p> <ul id="CD009971-list-0003"> <li> <p>A different dose of statin.</p> </li> </ul> </p> <p>We did not include any trials in which participants had existing statin therapy stopped or withdrawn before or immediately after surgery as part of the protocol. Co‐interventions or standard care should have been equivalent in all randomly assigned groups. We included trials where other features of care differ between intervention groups but considered these differences in the risk of bias assessment and performed sensitivity analyses to assess their impact on the results of the review.   </p> </section> <section id="CD009971-sec-0027"> <h4 class="title">Types of outcome measures</h4> <section id="CD009971-sec-0028"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD009971-list-0004"> <li> <p>All‐cause mortality within 30 days of surgery.</p> </li> <li> <p>Death from cardiovascular causes within 30 days of surgery. </p> </li> <li> <p>Non‐fatal cardiac events within 30 days of surgery. This endpoint included:</p> </li> </ul> <ul class="plain" id="CD009971-list-0005"> <li> <ul id="CD009971-list-0006"> <li> <p>Cardiac arrest;</p> </li> <li> <p>Myocardial infarction (MI) as defined by the universal definition (<a href="./references#CD009971-bbs2-0070" title="ThygesenK , AlpertJS , WhiteHD . Universal definition of myocardial infarction. Journal of the American College of Cardiology2007; Vol. 50, issue 22:2173‐95. [PUBMED: 18036459] ">Thygesen 2007</a>) and measured by appropriate biomarkers such as troponins (standard or sensitive), electrocardiogram (ECG) readings or clinical signs; and </p> </li> <li> <p>Myocardial necrosis as measured by increased troponin levels.</p> </li> </ul> </li> </ul> </p> <p>ECG evidence of ischaemia alone was not included as a cardiac event.</p> </section> <section id="CD009971-sec-0029"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009971-list-0007"> <li> <p>Non‐fatal stroke or transient ischaemic attack as measured by clinical or neurological deficit. </p> </li> <li> <p>Incident atrial fibrillation (AF) as measured by ECG readings.</p> </li> <li> <p>Acute kidney injury or renal failure as measured by increased serum creatine levels, decreased urine output or other biomarker. </p> </li> <li> <p>Participant‐reported outcomes such as quality of life or pain.</p> </li> <li> <p>Graft patency as measured by ultrasound or need to return to theatre.</p> </li> <li> <p>Length of stay: in hospital and intensive care unit.</p> </li> <li> <p>Clinical muscle syndromes (statin‐induced myopathy) including myositis and rhabdomyolysis.</p> </li> </ul> </p> <p>All outcomes, except length of hospital stay and graft patency, were assessed within 30 days of surgery. Any outcomes reported for periods longer than 30 days after surgery were not included, but those reported for shorter follow‐up times, such as seven days after surgery, were included. Subgroup analyses would have considered length of follow‐up if we had identified sufficient studies. </p> <p>Outcomes did not form part of the study eligibility assessment, so that studies that met the participant, intervention and comparison criteria were included in the review even if they reported no relevant outcomes. These studies were not included in the data analyses but were reported separately in <a href="./references#CD009971-sec-0110" title="">Characteristics of studies awaiting classification</a>. </p> </section> </section> </section> <section id="CD009971-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009971-sec-0031"> <h4 class="title">Electronic searches</h4> <p>We searched for eligible trials in the following databases: Cochrane Central Register of Controlled Trials (CENTRAL,<i>The Cochrane Library</i>, 2012 Issue 7, see <a href="./appendices#CD009971-sec-0077">Appendix 1</a>), MEDLINE via Ovid SP (1946 to 14 July 2012, see <a href="./appendices#CD009971-sec-0078">Appendix 2</a>), EMBASE via Ovid SP (1980 to 14 July 2012, see <a href="./appendices#CD009971-sec-0079">Appendix 3</a>), the CINAHL via EBSCO host (1982 to 14 July 2012, see <a href="./appendices#CD009971-sec-0080">Appendix 4</a>) and ISI Web of Science (1946 to 14 July 2012, see <a href="./appendices#CD009971-sec-0081">Appendix 5</a>). The highly sensitive filter for randomized controlled trials was applied in MEDLINE and EMBASE. We also searched trial registers such as <a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>, in February 2012 for ongoing studies. MEDLINE, EMBASE and CENTRAL were searched in March/ April 2012 with an earlier version of the search (<a href="./appendices#CD009971-sec-0082">Appendix 6</a>), and these results were combined with those from the main search. </p> <p>No language restrictions were applied. The search strategies were developed in collaboration with a clinical librarian and the CARG Trials Search Co‐ordinator. </p> </section> <section id="CD009971-sec-0032"> <h4 class="title">Searching other resources</h4> <p>We carried out forward citation on four papers: the two trials identified from the initial searches (<a href="./references#CD009971-bbs2-0010" title="PoldermansD . Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery: results from a randomized placebo controlled trial: DECREASE III. European Society of Cardiology Congress; August 2008; Munich, Germany. [CN‐00713534] PoldermansD . Statins and noncardiac surgery: current evidence and practical considerations. Cleveland Clinic Journal of Medicine2009; Vol. (76 Suppl 4):S79‐83. [PUBMED: 19880840] PoldermansD , SchoutenO , BaxJ , WinkelTA . Reducing cardiac risk in non‐cardiac surgery: evidence from the DECREASE studies. European Heart Journal Supplements2009; Vol. 11, issue A:A9‐A14. [WOS:000265835900003] SchoutenO , BoersmaE , HoeksSE , BennerR , VanUrkH , VanSambeekMRHM , et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. New England Journal of Medicine2009; Vol. 361, issue 10:980‐9. [EMBASE: 2009479335] SchoutenO , HoeksSE , BoersmaH , VouteMT , RavensbergenN , Bastos GoncalvesF , et al. Long‐term outcome of the DECREASE III trial; the impact of initiation of statin therapy prior to surgery. Abstract from European Society of Cardiology Congress, 2011, Paris France. Published in European Heart Journal. 2011; Vol. 32:332‐3. [EMBASE: 70534292] SchoutenO , HoeksSE , PoldermansD . Fluvastatin in patients undergoing vascular surgery (REPLY). New England Journal of Medicine2009; Vol. 361, issue 22:2187‐8. [WOS:000272117800018] SchoutenO , HoeksSE , VouteMT , BoersmaE , VerhagenHJ , PoldermansD . Long‐term benefit of perioperative statin use in patients undergoing vascular surgery: Results from the DECREASE III trial. Abstract from Vascular Annual Meeting of the Society for Vascular Surgery, 2011, Chicago, IL United States. Published in Journal of Vascular Surgery. 2011; Vol. 53 (6 SUPPL. 1):20S‐1S. [EMBASE: 70435717] SchoutenO , HoeksSE , VouteMT , RavensbergenN , Van DeLuijtgaardenK , Bastos GoncalvesF , et al. Perioperative myocardial ischemia: A preventable cause of poor long‐term outcome after vascular surgery?. Abstract from European Society of Cardiology Congress, 2011, Paris, France. Published in European Heart Journal. 2011; Vol. 32:556. [EMBASE: 70535145] SchoutenO , PoldermansD , VisserL , KertaiMD , KleinJ , vanUrkH , et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high‐risk patients undergoing non‐cardiac surgery: rationale and design of the DECREASE‐IV study. American Heart Journal2004; Vol. 148, issue 6:1047‐52. [WOS:000225970400021] SchoutenO , VerhagenHJ , PoldermansD . Endovascular repair of abdominal aortic aneurysm. New England Journal of Medicine2010; Vol. 363, issue 15:1480‐1; author reply 1481‐2. [EMBASE: 20931722] ">DECREASE III</a>; <a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a>) and two review papers (<a href="./references#CD009971-bbs2-0071" title="TwineCP , WilliamsIM . Systematic review and meta‐analysis of the effects of statin therapy on abdominal aortic aneurysms. The British Journal of Surgery2011;98(3):346‐53. [PUBMED: 21254006] ">Twine 2011</a>; <a href="./references#CD009971-bbs2-0074" title="WinchesterDE , WenX , XieL , BavryAA . Evidence of pre‐procedural statin therapy a meta‐analysis of randomized trials. Journal of the American College of Cardiology2010; Vol. 56, issue 14:1099‐109. [PUBMED: 20825761] ">Winchester 2010</a>). We used the cited reference search facility in Web of Science on 26 March 2012 to identify citing papers. We selected nine papers for backward citation (<a href="./references#CD009971-bbs2-0035" title="BiccardBM , SearJW , FoexP . The pharmaco‐economics of peri‐operative statin therapy. Anaesthesia2005; Vol. 60, issue 11:1059‐63. [EMBASE: 2005522759] ">Biccard 2005</a>; <a href="./references#CD009971-bbs2-0039" title="ChopraV , WesorickDH , SussmanJB , GreeneT , RogersM , FroehlichJB , et al. Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta‐analysis. Archives of Surgery2012; Vol. 147, issue 2:181‐9. [PUBMED: 22351917] ">Chopra 2012</a>; <a href="./references#CD009971-bbs2-0041" title="DagherNN , ModrallJG . Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins. Seminars in Vascular Surgery2007; Vol. 20, issue 1:10‐4. [EMBASE: 2007147774] ">Dagher 2007</a>; <a href="./references#CD009971-bbs2-0046" title="HindlerK , ShawAD , SamuelsJ , FultonS , CollardCD , RiedelB . Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology2006; Vol. 105, issue 6:1260‐72. [2006579027] ">Hindler 2006</a>; <a href="./references#CD009971-bbs2-0048" title="KapoorAS , KanjiH , BuckinghamJ , DevereauxPJ , McAlisterFA . Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ2006; Vol. 333, issue 7579:1149. [PUBMED: 17088313] ">Kapoor 2006</a>; <a href="./references#CD009971-bbs2-0063" title="ParaskevasKI , MikhailidisDP , VeithFJ . Optimal statin type and dosage for vascular patients. Journal of Vascular Surgery2011; Vol. 53, issue 3:837‐44. [PUBMED: 21215572] ">Paraskevas 2011</a>; <a href="./references#CD009971-bbs2-0067" title="SinghN , AugoustidesJG . Perioperative protective effects of statins. F1000 Medicine Reports1000; Vol. 2. [PUBMED: 20948850] ">Singh 1000</a>; <a href="./references#CD009971-bbs2-0068" title="StalenhoefAFH . The benefit of statins in non‐cardiac vascular surgery patients. Journal of Vascular Surgery2009; Vol. 49, issue 1:260‐5. [EMBASE: 2009036987] ">Stalenhoef 2009</a>; <a href="./references#CD009971-bbs2-0074" title="WinchesterDE , WenX , XieL , BavryAA . Evidence of pre‐procedural statin therapy a meta‐analysis of randomized trials. Journal of the American College of Cardiology2010; Vol. 56, issue 14:1099‐109. [PUBMED: 20825761] ">Winchester 2010</a>) </p> </section> </section> <section id="CD009971-sec-0033"> <h3 class="title" id="CD009971-sec-0033">Data collection and analysis</h3> <section id="CD009971-sec-0034"> <h4 class="title">Selection of studies</h4> <p>Results of the searches were collated and duplicates were removed. The selection of eligible articles took place in two stages. </p> <p>All titles and abstracts were screened by AN and one of RDS, PA, AFS or medical student assistant to remove studies that were very unlikely to be eligible. This included studies that were clearly of an ineligible design or that included an ineligible study population or intervention. A pilot of 100 titles was reviewed with each pair of screeners before we proceeded with the remaining titles to clarify criteria for discarding articles at this stage. If no abstract was available but the title was possibly relevant, we obtained the full text of the article. </p> <p>When we had screened all titles and abstracts, the full texts of potentially relevant titles were reviewed by AN or either SRL or RDS and information recorded on the study eligibility form. This form is included in <a href="./appendices#CD009971-sec-0083">Appendix 7</a>. A pilot of 10 papers was read, and then the investigators discussed results to clarify the criteria for discarding articles at this stage and to modify the form as required. All potentially relevant papers were then read and the results of the two investigators compared. Any differences that we could not resolve were referred to AFS or PA. </p> </section> <section id="CD009971-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>Data were extracted independently from eligible studies by AN/SRL using a paper data extraction form (<a href="./appendices#CD009971-sec-0083">Appendix 7</a>). We merged data from multiple eligible publications from the same study into a single data extraction form. </p> <p>We included the following data items on the data extraction form:</p> <p> <ul id="CD009971-list-0008"> <li> <p>Study design: randomization unit, cluster or participant; sequence generation or other randomization method; </p> </li> <li> <p>Power calculations with baseline risk and effect size assumed;</p> </li> <li> <p>Participant group: age, demographic, type of surgical operation;</p> </li> <li> <p>Intervention: type of statin prescribed, timing and length of course, dosage, standard care given; </p> </li> <li> <p>Comparison group: placebo, no treatment or different dose of statin;</p> </li> <li> <p>Outcomes: outcomes and time points (i) collected, (ii) reported. For each outcome: definition, unit of measurement, timing; and </p> </li> <li> <p>Results: numbers of participants (and number of clusters) assigned to each intervention group. For each outcome: sample size, summary data for each intervention (two‐by‐two table where possible for dichotomous data, means and standard deviations for continuous data), P values and confidence intervals. </p> </li> </ul> </p> <p>AN and SRL met to compare results and prepare a final agreed form for each study. If relevant information or data were not available in the paper, we contacted the lead author to request the additional details.The agreed final data extraction form was entered into RevMan by AN and checked by SRL. </p> </section> <section id="CD009971-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used the Cochrane risk of bias tool (<a href="./references#CD009971-bbs2-0045" title="HigginsJPT , AltmanDG , GøtzschePC , JüniP , MoherD , OxmanAD , et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ2011; Vol. 343:d5928. [PUBMED: 22008217] ">Higgins 2011a</a>). We considered the following Items: </p> <p> <ul id="CD009971-list-0009"> <li> <p>Whether sequence generation  was adequate;</p> </li> <li> <p>Allocation concealment;</p> </li> <li> <p>Blinding of participants, personnel and outcomes assessors;</p> </li> <li> <p>Incomplete outcome data;</p> </li> <li> <p>Selective outcomes reporting; and</p> </li> <li> <p>Other potential sources of bias.</p> </li> </ul> </p> <p>We considered blinding and incomplete outcome data separately for each outcome. Where possible, we obtained the protocol for the study and compared the methods reported with those outlined in the protocol to identify post hoc changes. </p> <p>We completed a risk of bias table for each eligible study and outcome using the categories low, high and unclear risk of bias. </p> </section> <section id="CD009971-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes such as mortality and the occurrence of cardiac events, we entered total and numbers of events, respectively, into RevMan 5.1 (<a href="./references#CD009971-bbs2-0064" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 5.1</a>) and calculated risk ratios with 95% confidence intervals (CIs). If data had been presented in other forms, such as hazard ratios, and we had been unable to obtain the required tabular data from the study authors, we would have used the generic inverse variance option in RevMan. For continuous measures, such as length of stay, we aimed to calculate weighted mean differences (WMDs) using means and standard deviations. Where these data were unavailable, we reported medians and interquartile range but did not include these results in a meta‐analysis. </p> </section> <section id="CD009971-sec-0038"> <h4 class="title">Unit of analysis issues</h4> <p>We did not find any cluster‐randomized or cross‐over trials. If any such trials had been included, we would have extracted data directly only if the analysis had properly accounted for the cluster design, using methods such as multilevel modelling or generalized estimating equations. If these adjustments had not been made within the report, we planned to perform approximate analyses by recalculating standard errors or sample sizes based on the design effect (see Section 16.3.6 of <a href="./references#CD009971-bbs2-0044" title="Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). The resulting effect estimates and their standard errors would have been analysed using the generic inverse variance method in RevMan. </p> </section> <section id="CD009971-sec-0039"> <h4 class="title">Dealing with missing data</h4> <p>We contacted authors to clarify any missing or unclear follow‐up and outcome data. If missing outcome data remained a concern, we planned to undertake sensitivity analyses to compare the effects of complete case analysis, worst case scenario and last observation carried forward options on the results of any individual study and on any meta‐analysis undertaken. </p> </section> <section id="CD009971-sec-0040"> <h4 class="title">Assessment of heterogeneity</h4> <p>We anticipated that there might be considerable heterogeneity between studies because of differences in: </p> <p> <ul id="CD009971-list-0010"> <li> <p>Timing and duration of statin before surgery;</p> </li> <li> <p>Type and dose of statin;</p> </li> <li> <p>Components of standard care; and</p> </li> <li> <p>Timing of outcome measurement (e.g. seven days, 28 days).</p> </li> </ul> </p> <p>If we had included sufficient studies in any single meta‐analysis, we planned to study heterogeneity between studies based on participant group, setting and type of intervention using the Chi<sup>2</sup> and I<sup>2</sup> statistics. Important heterogeneity (Chi<sup>2</sup> P &lt; 0.1 and I<sup>2</sup> &gt; 50%) would have been investigated, where possible, by subgroup analyses and meta‐regression, particularly for the effect of dosage or duration of statin therapy. </p> </section> <section id="CD009971-sec-0041"> <h4 class="title">Assessment of reporting biases</h4> <p>Reporting bias may occur within studies, with certain*‐ outcomes not reported. Where a report or the original protocol suggested that data on an outcome were collected but it was not reported in the paper, we contacted the authors and requested the data. If 10 or more studies had been included in any single meta‐analysis, funnel plots would have been examined to visually assess the presence of publication bias and Egger’s test used to test for asymmetry.  </p> </section> <section id="CD009971-sec-0042"> <h4 class="title">Data synthesis</h4> <p>The extent of heterogeneity was considered before any meta‐analysis was attempted. Any I<sup>2</sup> values in excess of 80% for any group of studies argued against an overall estimate being presented. Where we had sufficient studies to combine results, differences in study size and between studies in the duration and type of statin, standard care and type of surgery suggested that a random‐effects model would be the most suitable choice. Mantel‐Haenszel risk ratios were used where possible for dichotomous outcomes as the outcomes were not rare. </p> </section> <section id="CD009971-sec-0043"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If data had been sufficient we planned to investigate the following subgroups, which could account for heterogeneity between studies: </p> <p> <ul id="CD009971-list-0011"> <li> <p>Type of surgical intervention;</p> </li> <li> <p>Emergency or elective surgery;</p> </li> <li> <p>Duration of statin use; and</p> </li> <li> <p>Timing of outcome measurement.</p> </li> </ul> </p> <p>We planned to assess differences in effect size between subgroups in RevMan, using I<sup>2</sup> estimates (Section 9.6.3.1 of <a href="./references#CD009971-bbs2-0044" title="Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>) and to combine results in smaller groups if appropriate. </p> </section> <section id="CD009971-sec-0044"> <h4 class="title">Sensitivity analysis</h4> <p>If sufficient studies had been found, we aimed to undertake analyses to explore the contributions of: </p> <p> <ul id="CD009971-list-0012"> <li> <p>Unpublished studies;     </p> </li> <li> <p>Risk of bias; and</p> </li> <li> <p>Risk of missing outcome data</p> </li> </ul> </p> <section id="CD009971-sec-0045"> <h5 class="title">Summary of findings</h5> <p>We used the principles of the GRADE system to assess the quality of the body of evidence associated with the following specific outcomes in our review (<a href="./references#CD009971-bbs2-0043" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchunemannHJ . What is "quality of evidence" and why is it important to clinicians?. BMJ2008; Vol. 336, issue 7651:995‐8. [PUBMED: 18456631] '>Guyatt 2008</a>): </p> <p> <ul id="CD009971-list-0013"> <li> <p>All‐cause mortality within 30 days of surgery;</p> </li> <li> <p>Death from cardiovascular causes within 30 days of surgery; </p> </li> <li> <p>Non‐fatal cardiac or stroke events within 30 days of surgery;</p> </li> <li> <p>Adverse muscle effects; and</p> </li> <li> <p>Participant‐reported outcomes.</p> </li> </ul> </p> <p>We constructed a 'Summary of findings' (SoF) table using the GRADE software. The GRADE approach appraises the quality of evidence for an outcome and assesses how confident we can be that our estimate of effect or association reflects the real association. The quality measures considered include risk of bias (methodologic quality), directness of the evidence, heterogeneity of the data, precision of effect estimates and risk of publication bias. The summary of findings table was completed by AN and checked by SRL. We resolved disagreements by discussion and, if necessary, consultation with AFS or PA. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009971-sec-0046" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009971-sec-0046"></div> <section id="CD009971-sec-0047"> <h3 class="title">Description of studies</h3> <section id="CD009971-sec-0048"> <h4 class="title">Results of the search</h4> <p>Our search is summarized in <a href="#CD009971-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD009971-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Sudy flow diagram." data-id="CD009971-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Sudy flow diagram.</p> </div> </div> </div> <p>We identified 5804 references through searches of electronic databases and 278 from forward citation searching. We removed duplicates, which resulted in 5476 unique references. We found no extra studies via backward citation. We excluded 5356 records on the basis of titles and abstracts and then reviewed 120 full text papers. Of these, 19 were eligible and 101 ineligible. We found three eligible clinical trials by searching trial databases－one of which had an eligible publication (<a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>). </p> </section> <section id="CD009971-sec-0049"> <h4 class="title">Included studies</h4> <p>We found nine papers from five eligible studies reporting outcomes<b><i>(</i> </b><a href="./references#CD009971-bbs2-0001" title="AlmeidaR , CoelhoOR , MenesesFH , OliveiraG , MolinariG , FrancaR , et al. The APVS (atorvastatin in the perioperative of vascular surgery) study. Abstract from World Congress of Cardiology Scientific Sessions 2010, Beijing China. Published in Circulation 2010. 2010; Vol. 122 (2):e345. [EMBASE: 70233157] AlmeidaRC , CoelhoOR , MenezesFH , OliveiraGP , MolinariGJPD , FrancaRP , et al. Comparison of effects of high dose (80 mg) atorvastatin versus 20 mg atorvastatin on C‐reactive protein and lipoproteins in patients undergoing major vascular surgery. Abstract from European Society of Cardiolog Congress 2010 Stockholm, Sweden. Published in European Heart Journal. 2010; Vol. 31:64. [EMBASE: 70279734] ">APVS study</a>; <a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a>; <a href="./references#CD009971-bbs2-0004" title="RahmanMA , KhanJA , MazariFAK , MockfordK , McCollumPT , ChetterIC . A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Annals of Vascular Surgery2011; Vol. 25, issue 1:32‐8. [EMBASE: 2010702366] ">Rahman 1995</a>; <a href="./references#CD009971-bbs2-0005" title="RamoOJ , JuhaL , MarttiS , HannuH , PauliinaRM , RistoM . Effects of lovastatin in prevention of restenosis after percutaneous transluminal angioplasty in lower limbs. International Journal of Angiology1995; Vol. 4, issue 4:173‐6. [EMBASE: 1995373334] ">Ramo 1995</a>; <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>). We also found 10 papers reporting on seven studies that were eligible (RCTs studying perioperative statin used in participants undergoing vascular surgery ) but had reported no relevant outcome data (<a href="./references#CD009971-bbs2-0026" title="CortellaroM , ConfrancescoE , ArbustiniE , RossiF , NegriA , TremoliE , et al. Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: The ATROCAP Study. Thrombosis and Haemostasis2002; Vol. 88, issue 1:41‐7. [EMBASE: 2002247459] ">ATROCAP study</a>; <a href="./references#CD009971-bbs2-0027" title="CrisbyM , Nordin‐FredrikssonG , ShahPK , YanoJ , ZhuJ , NilssonJ . Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation2001; Vol. 103, issue 7:926‐33. [PUBMED: 11181465] ">Crisby 2001</a>; <a href="./references#CD009971-bbs2-0028" title="CipolloneF , FaziaM , IezziA , ZucchelliM , PiniB , DeCesareD , et al. Suppression of the functionally coupled cyclooxygenase‐2/prostaglandin E synthase as a basis of simvastatin‐dependent plaque stabilization in humans. Circulation2003; Vol. 107, issue 11:1479‐85. [PUBMED: 12654603] CuccurulloC , IezziA , FaziaML , DeCesareD , DiFrancescoA , MuraroR , et al. Suppression of rage as a basis of simvastatin‐dependent plaque stabilization in type 2 diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology2006; Vol. 26, issue 12:2716‐23. [EMBASE: 2006569544] ">Cuccurollo 2006</a>; <a href="./references#CD009971-bbs2-0029" title="EvansJ . Pre‐operative simvastatin reduces MMP‐9 in the wall of abdominal aortic aneurysms: a randomized trial. British Journal of Surgery2007, issue Suppl 1:8‐9. [CENTRAL: CN‐00653659] EvansJ , PowellJT , SchwalbeE , LoftusIM , ThompsonMM . Simvastatin attenuates the activity of matrix metalloprotease‐9 in aneurysmal aortic tissue. European Journal of Vascular and Endovascular Surgery2007; Vol. 34, issue 3:302‐3. [EMBASE: 2007378477] EvansJ , SchwalbeE , LoftusIM , PowellJT , ThompsonMM . Pre‐operative simvastatin reduces MMP‐9 in the wall of abdominal aortic aneurysms: a randomised trial. The Vascular Society of Great Britain &amp; Ireland Yearbook2006:79. [CENTRAL: CN‐00691124] ">Evans 2007</a>; <a href="./references#CD009971-bbs2-0030" title="KajimotoK , MiyauchiK , KasaiT , ShimadaK , KojimaY , ShimadaA , et al. Short‐term 20‐mg atorvastatin therapy reduces key inflammatory factors including c‐Jun N‐terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall. Atherosclerosis2009; Vol. 206, issue 2:505‐11. [EMBASE: 2009510035] ">Kajimoto 2009</a>; <a href="./references#CD009971-bbs2-0031" title="Martin‐VenturaJL , Blanco‐ColioLM , Gomez‐HernandezA , Munoz‐GarciaB , VegaM , SerranoJ , et al. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month. Stroke2005; Vol. 36, issue 8:1796‐800. [EMBASE: 2005353457] ">Martin Ventura 2005</a>; <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a>). These studies are mainly small and focused on cellular outcomes or biomarkers in the vessel wall. We contacted the authors to clarify design and duration of statin therapy and to ask whether clinical outcomes were available.The investigators of the <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a> supplied clinical outcome data, and so this study has been added as an eligible study－giving a total of 11 papers from six eligible studies.These remaining six eligible studies with no outcome data are summarized in the <a href="./references#CD009971-sec-0110" title="">Characteristics of studies awaiting classification</a> table. The six eligible studies are summarised in <a href="./references#CD009971-sec-0108" title="">Characteristics of included studies</a>. </p> <section id="CD009971-sec-0050"> <h5 class="title">Participants</h5> <p>Five study populations were exclusively participants who had undergone vascular surgery either a mixture of procedures, including abdominal aortic aneurysm (AAA) repair, carotid endarterectomy (CEA) and lower limb arterial surgery or amputation (<a href="./references#CD009971-bbs2-0001" title="AlmeidaR , CoelhoOR , MenesesFH , OliveiraG , MolinariG , FrancaR , et al. The APVS (atorvastatin in the perioperative of vascular surgery) study. Abstract from World Congress of Cardiology Scientific Sessions 2010, Beijing China. Published in Circulation 2010. 2010; Vol. 122 (2):e345. [EMBASE: 70233157] AlmeidaRC , CoelhoOR , MenezesFH , OliveiraGP , MolinariGJPD , FrancaRP , et al. Comparison of effects of high dose (80 mg) atorvastatin versus 20 mg atorvastatin on C‐reactive protein and lipoproteins in patients undergoing major vascular surgery. Abstract from European Society of Cardiolog Congress 2010 Stockholm, Sweden. Published in European Heart Journal. 2010; Vol. 31:64. [EMBASE: 70279734] ">APVS study</a>; <a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a>), or a single procedure－open AAA repair (<a href="./references#CD009971-bbs2-0004" title="RahmanMA , KhanJA , MazariFAK , MockfordK , McCollumPT , ChetterIC . A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Annals of Vascular Surgery2011; Vol. 25, issue 1:32‐8. [EMBASE: 2010702366] ">Rahman 1995</a>), CEA (<a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a>) or lower limb angioplasty (<a href="./references#CD009971-bbs2-0005" title="RamoOJ , JuhaL , MarttiS , HannuH , PauliinaRM , RistoM . Effects of lovastatin in prevention of restenosis after percutaneous transluminal angioplasty in lower limbs. International Journal of Angiology1995; Vol. 4, issue 4:173‐6. [EMBASE: 1995373334] ">Ramo 1995</a>). The Star VaS study included a minority of nonvascular participants (<a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>), but we were able to obtain outcome data on participants undergoing vascular surgery only. Participants were not selected on the basis of lipid level, and in all studies, participants were required not to be on statins before enrolment in the study. In some studies, this led to a considerable loss of eligible participants. For instance, during recruitment for the <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>, 815 out of 1037 potential subjects were excluded because of statin use. We found no studies in which existing statin users were randomly assigned to different dosages. </p> <p><b>Interventions / comparisons</b> </p> <p>Atorvastatin was the intervention drug in five studies, with doses varying from 80 mg/day ( <a href="./references#CD009971-bbs2-0001" title="AlmeidaR , CoelhoOR , MenesesFH , OliveiraG , MolinariG , FrancaR , et al. The APVS (atorvastatin in the perioperative of vascular surgery) study. Abstract from World Congress of Cardiology Scientific Sessions 2010, Beijing China. Published in Circulation 2010. 2010; Vol. 122 (2):e345. [EMBASE: 70233157] AlmeidaRC , CoelhoOR , MenezesFH , OliveiraGP , MolinariGJPD , FrancaRP , et al. Comparison of effects of high dose (80 mg) atorvastatin versus 20 mg atorvastatin on C‐reactive protein and lipoproteins in patients undergoing major vascular surgery. Abstract from European Society of Cardiolog Congress 2010 Stockholm, Sweden. Published in European Heart Journal. 2010; Vol. 31:64. [EMBASE: 70279734] ">APVS study</a>; <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a>; <a href="./references#CD009971-bbs2-0004" title="RahmanMA , KhanJA , MazariFAK , MockfordK , McCollumPT , ChetterIC . A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Annals of Vascular Surgery2011; Vol. 25, issue 1:32‐8. [EMBASE: 2010702366] ">Rahman 1995</a>; <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>) to 20 mg/day (<a href="./references#CD009971-bbs2-0001" title="AlmeidaR , CoelhoOR , MenesesFH , OliveiraG , MolinariG , FrancaR , et al. The APVS (atorvastatin in the perioperative of vascular surgery) study. Abstract from World Congress of Cardiology Scientific Sessions 2010, Beijing China. Published in Circulation 2010. 2010; Vol. 122 (2):e345. [EMBASE: 70233157] AlmeidaRC , CoelhoOR , MenezesFH , OliveiraGP , MolinariGJPD , FrancaRP , et al. Comparison of effects of high dose (80 mg) atorvastatin versus 20 mg atorvastatin on C‐reactive protein and lipoproteins in patients undergoing major vascular surgery. Abstract from European Society of Cardiolog Congress 2010 Stockholm, Sweden. Published in European Heart Journal. 2010; Vol. 31:64. [EMBASE: 70279734] ">APVS study</a>; <a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a>) or 10 mg/day (<a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a>). <a href="./references#CD009971-bbs2-0005" title="RamoOJ , JuhaL , MarttiS , HannuH , PauliinaRM , RistoM . Effects of lovastatin in prevention of restenosis after percutaneous transluminal angioplasty in lower limbs. International Journal of Angiology1995; Vol. 4, issue 4:173‐6. [EMBASE: 1995373334] ">Ramo 1995</a> used 20 mg/day lovastatin. Three studies compared statin with a placebo ( <a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a>; <a href="./references#CD009971-bbs2-0004" title="RahmanMA , KhanJA , MazariFAK , MockfordK , McCollumPT , ChetterIC . A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Annals of Vascular Surgery2011; Vol. 25, issue 1:32‐8. [EMBASE: 2010702366] ">Rahman 1995</a>; <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>) and one compared statin with no additional treatment (<a href="./references#CD009971-bbs2-0005" title="RamoOJ , JuhaL , MarttiS , HannuH , PauliinaRM , RistoM . Effects of lovastatin in prevention of restenosis after percutaneous transluminal angioplasty in lower limbs. International Journal of Angiology1995; Vol. 4, issue 4:173‐6. [EMBASE: 1995373334] ">Ramo 1995</a>). Two studies compared high‐dose (80 mg/day) atorvastatin with low‐dose (20 mg/day) atorvastatin in the <a href="./references#CD009971-bbs2-0001" title="AlmeidaR , CoelhoOR , MenesesFH , OliveiraG , MolinariG , FrancaR , et al. The APVS (atorvastatin in the perioperative of vascular surgery) study. Abstract from World Congress of Cardiology Scientific Sessions 2010, Beijing China. Published in Circulation 2010. 2010; Vol. 122 (2):e345. [EMBASE: 70233157] AlmeidaRC , CoelhoOR , MenezesFH , OliveiraGP , MolinariGJPD , FrancaRP , et al. Comparison of effects of high dose (80 mg) atorvastatin versus 20 mg atorvastatin on C‐reactive protein and lipoproteins in patients undergoing major vascular surgery. Abstract from European Society of Cardiolog Congress 2010 Stockholm, Sweden. Published in European Heart Journal. 2010; Vol. 31:64. [EMBASE: 70279734] ">APVS study</a> or 10 mg/day in the <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a>. The <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a> also had a control group of cholestyramine and sitosterol, so this study is entered in both comparisons, with the two dosage groups of atorvastatin combined for comparison of statin versus placebo/control. </p> <p>In most studies, the statin intervention was started three to four weeks before surgery. In the angioplasty study－when the procedure was often urgent－statins were commenced on average two days before the procedure (<a href="./references#CD009971-bbs2-0005" title="RamoOJ , JuhaL , MarttiS , HannuH , PauliinaRM , RistoM . Effects of lovastatin in prevention of restenosis after percutaneous transluminal angioplasty in lower limbs. International Journal of Angiology1995; Vol. 4, issue 4:173‐6. [EMBASE: 1995373334] ">Ramo 1995</a>). The STAR Vas study had two intervention arms and compared both statin therapy commenced seven days before (AA group) and on the day of surgery (PA group) with placebo therapy (PP group). The AA and PA groups were combined in our analyses. </p> <p>Ramo et al, studying angioplasty participants, prescribed aspirin to both intervention and control groups (<a href="./references#CD009971-bbs2-0005" title="RamoOJ , JuhaL , MarttiS , HannuH , PauliinaRM , RistoM . Effects of lovastatin in prevention of restenosis after percutaneous transluminal angioplasty in lower limbs. International Journal of Angiology1995; Vol. 4, issue 4:173‐6. [EMBASE: 1995373334] ">Ramo 1995</a>). In other studies, the use of co‐interventions was left to the discretion.of the clinical team (<a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a>; <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>). </p> </section> </section> <section id="CD009971-sec-0051"> <h4 class="title">Excluded studies</h4> <p>We reviewed 101 studies in full text that were ineligible or excluded. Mostof these were editorials, reviews or reports from observational data. We have summarized only 19 publications from randomized trials that were excluded in the <a href="./references#CD009971-sec-0109" title="">Characteristics of excluded studies</a> table. The most important exclusion is the 10 articles related to the <a href="./references#CD009971-bbs2-0010" title="PoldermansD . Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery: results from a randomized placebo controlled trial: DECREASE III. European Society of Cardiology Congress; August 2008; Munich, Germany. [CN‐00713534] PoldermansD . Statins and noncardiac surgery: current evidence and practical considerations. Cleveland Clinic Journal of Medicine2009; Vol. (76 Suppl 4):S79‐83. [PUBMED: 19880840] PoldermansD , SchoutenO , BaxJ , WinkelTA . Reducing cardiac risk in non‐cardiac surgery: evidence from the DECREASE studies. European Heart Journal Supplements2009; Vol. 11, issue A:A9‐A14. [WOS:000265835900003] SchoutenO , BoersmaE , HoeksSE , BennerR , VanUrkH , VanSambeekMRHM , et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. New England Journal of Medicine2009; Vol. 361, issue 10:980‐9. [EMBASE: 2009479335] SchoutenO , HoeksSE , BoersmaH , VouteMT , RavensbergenN , Bastos GoncalvesF , et al. Long‐term outcome of the DECREASE III trial; the impact of initiation of statin therapy prior to surgery. Abstract from European Society of Cardiology Congress, 2011, Paris France. Published in European Heart Journal. 2011; Vol. 32:332‐3. [EMBASE: 70534292] SchoutenO , HoeksSE , PoldermansD . Fluvastatin in patients undergoing vascular surgery (REPLY). New England Journal of Medicine2009; Vol. 361, issue 22:2187‐8. [WOS:000272117800018] SchoutenO , HoeksSE , VouteMT , BoersmaE , VerhagenHJ , PoldermansD . Long‐term benefit of perioperative statin use in patients undergoing vascular surgery: Results from the DECREASE III trial. Abstract from Vascular Annual Meeting of the Society for Vascular Surgery, 2011, Chicago, IL United States. Published in Journal of Vascular Surgery. 2011; Vol. 53 (6 SUPPL. 1):20S‐1S. [EMBASE: 70435717] SchoutenO , HoeksSE , VouteMT , RavensbergenN , Van DeLuijtgaardenK , Bastos GoncalvesF , et al. Perioperative myocardial ischemia: A preventable cause of poor long‐term outcome after vascular surgery?. Abstract from European Society of Cardiology Congress, 2011, Paris, France. Published in European Heart Journal. 2011; Vol. 32:556. [EMBASE: 70535145] SchoutenO , PoldermansD , VisserL , KertaiMD , KleinJ , vanUrkH , et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high‐risk patients undergoing non‐cardiac surgery: rationale and design of the DECREASE‐IV study. American Heart Journal2004; Vol. 148, issue 6:1047‐52. [WOS:000225970400021] SchoutenO , VerhagenHJ , PoldermansD . Endovascular repair of abdominal aortic aneurysm. New England Journal of Medicine2010; Vol. 363, issue 15:1480‐1; author reply 1481‐2. [EMBASE: 20931722] ">DECREASE III</a> study. After careful consideration and consultation with CARG Co‐ordinating Editors (Nathan Pace and Ann Møller), we decided to exclude this study because of the dismissal of principal investigator Professor Polderman for breaches of academic integrity for recurrent and systematic problems in his research activity (<a href="./references#CD009971-bbs2-0042" title="Committee for the Investigation of Scientific Integrity. Erasmus MC, University Medical Center Rotterdam. Investigation into possible violation of scientific integrity. http://www.erasmusmc.nl/5663/135857/3664573/3397899/report_summary_investigation_integrity. November 2011. ">Erasmus 2011</a>). We excluded the Heart Protection Study (HPS) as it reported the effects of statin therapy on outcomes in peripheral arterial disease (PAD) participants considered long‐term not perioperative therapy (<a href="./references#CD009971-bbs2-0016" title="Heart Protection Study Collaborative G. Randomized trial of the effects of cholesterol‐lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high‐risk conditions. Journal of Vascular Surgery2007, issue 4:645‐54; discussion 653‐4. [CENTRAL: CN‐00579613] ">HPS 2007</a>). Other excluded studies examined PAD participants who were not undergoing surgery (<a href="./references#CD009971-bbs2-0008" title="BlannAD , GurneyD , HughesE , BugginsP , SilvermanSH , LipGY . Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease. The American Journal of Cardiology2001, issue 1:A7‐8, 89‐92. [CENTRAL: CN‐00348899] ">Blann 2001</a>; <a href="./references#CD009971-bbs2-0014" title="HagenaarsT , GussenhovenEJ , PoldermansD , VanUrkH , Van derLugtA . Rationale and design for the SARIS trial; effect of statin on atherosclerosis and vascular remodeling assessed with intravascular sonography. Cardiovascular Drugs and Therapy2001; Vol. 15, issue 4:339‐43. [EMBASE: 2001428209] ">Hagenaars 2001</a>). In two studies, both intervention and control groups received statins (<a href="./references#CD009971-bbs2-0012" title="LumsdenAB , RiceTW , ChenC , ZhouW , LinPH , BrayP , et al. Peripheral arterial occlusive disease: magnetic resonance imaging and the role of aggressive medical management. World Journal of Surgery2007; Vol. 31, issue 4:695‐704. [EMBASE: 2007158537] ">ELIMIT 2007</a>; <a href="./references#CD009971-bbs2-0020" title="Martin‐VenturaJL , Muoz‐GarciaB , Blanco‐ColioLM , Martin‐ConejeroA , Madrigal‐MatuteJ , VegaM , et al. Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis. Kidney International2008; Vol. 74(Suppl 111):S71‐4. [EMBASE: 2008568017] ">Martin‐Ventura 2008</a>). For clarity, we have listed some of the observational studies on vascular surgery participants that we excluded on the basis of title and abstract but that have been reported in other reviews (<a href="./references#CD009971-bbs2-0046" title="HindlerK , ShawAD , SamuelsJ , FultonS , CollardCD , RiedelB . Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology2006; Vol. 105, issue 6:1260‐72. [2006579027] ">Hindler 2006</a>; <a href="./references#CD009971-bbs2-0048" title="KapoorAS , KanjiH , BuckinghamJ , DevereauxPJ , McAlisterFA . Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ2006; Vol. 333, issue 7579:1149. [PUBMED: 17088313] ">Kapoor 2006</a>; <a href="./references#CD009971-bbs2-0068" title="StalenhoefAFH . The benefit of statins in non‐cardiac vascular surgery patients. Journal of Vascular Surgery2009; Vol. 49, issue 1:260‐5. [EMBASE: 2009036987] ">Stalenhoef 2009</a>). </p> <section id="CD009971-sec-0052"> <h5 class="title"><i>Ongoing studies</i> </h5> <p>We found three studies in our review of clinical trials databases. The <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a> has published results and is considered with included studies. We were able to obtain from the authors outcome data on vascular surgery participants. The <a href="./references#CD009971-bbs2-0032" title="Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD).. Ongoing study August 2012. Hope to complete recruitment by November 2014.. ">LOAD study</a> has just commenced and expects to complete recruitment in 2014. It includes vascular surgery as well other types of surgery in high－cardiovascular risk participants. The Clinical Utility of Endothelial Dysfunction in PAD study is focused on endothelial outcomes but is a randomized trial of statin use in participants undergoing vascular surgery(<a href="./references#CD009971-bbs2-0033" title="Clinical Utility of Endothelial Dysfunction in PAD. . Ongoing study May 2004. Estimated study completion date June 2012.. ">Vita 2012</a>). </p> </section> </section> </section> <section id="CD009971-sec-0053"> <h3 class="title">Risk of bias in included studies</h3> <p>Our risk of bias assessments for each included study are summarized in <a href="#CD009971-fig-0002">Figure 2</a> and as percentages across all studies in <a href="#CD009971-fig-0003">Figure 3</a>. Details and reasons for each assessment are listed in <a href="./references#CD009971-sec-0108" title="">Characteristics of included studies</a>. </p> <div class="figure" id="CD009971-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009971-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD009971-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009971-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD009971-sec-0054"> <h4 class="title">Allocation</h4> <p>Three studies gave sufficient details about their methods for random sequence generation and allocation concealment to be assessed as at low risk of selection bias (<a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a>; <a href="./references#CD009971-bbs2-0004" title="RahmanMA , KhanJA , MazariFAK , MockfordK , McCollumPT , ChetterIC . A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Annals of Vascular Surgery2011; Vol. 25, issue 1:32‐8. [EMBASE: 2010702366] ">Rahman 1995</a>; <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>).Three studies described the allocation as randomly assigned but gave insufficient detail to allow assessment of either sequence generation or allocation concealment (<a href="./references#CD009971-bbs2-0001" title="AlmeidaR , CoelhoOR , MenesesFH , OliveiraG , MolinariG , FrancaR , et al. The APVS (atorvastatin in the perioperative of vascular surgery) study. Abstract from World Congress of Cardiology Scientific Sessions 2010, Beijing China. Published in Circulation 2010. 2010; Vol. 122 (2):e345. [EMBASE: 70233157] AlmeidaRC , CoelhoOR , MenezesFH , OliveiraGP , MolinariGJPD , FrancaRP , et al. Comparison of effects of high dose (80 mg) atorvastatin versus 20 mg atorvastatin on C‐reactive protein and lipoproteins in patients undergoing major vascular surgery. Abstract from European Society of Cardiolog Congress 2010 Stockholm, Sweden. Published in European Heart Journal. 2010; Vol. 31:64. [EMBASE: 70279734] ">APVS study</a>; <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a>; <a href="./references#CD009971-bbs2-0005" title="RamoOJ , JuhaL , MarttiS , HannuH , PauliinaRM , RistoM . Effects of lovastatin in prevention of restenosis after percutaneous transluminal angioplasty in lower limbs. International Journal of Angiology1995; Vol. 4, issue 4:173‐6. [EMBASE: 1995373334] ">Ramo 1995</a>). In general, the distribution of baseline characteristics and the type of operation between intervention and control groups were similar, suggesting effective randomization. However in Ramo et al, where no details of randomization method were given, the intervention group's clinical condition baseline was worse, with fewer run‐off vessels. The effect of this bias would be to decrease any protective effect of statins (<a href="./references#CD009971-bbs2-0005" title="RamoOJ , JuhaL , MarttiS , HannuH , PauliinaRM , RistoM . Effects of lovastatin in prevention of restenosis after percutaneous transluminal angioplasty in lower limbs. International Journal of Angiology1995; Vol. 4, issue 4:173‐6. [EMBASE: 1995373334] ">Ramo 1995</a>), so we did not assess this as high risk. </p> </section> <section id="CD009971-sec-0055"> <h4 class="title">Blinding</h4> <p>We have separated these assessments by type of outcome as the impact of staff or participant knowledge of allocation may vary across different outcomes. </p> <p>Of the six studies reporting clinical endpoints (death, non‐fatal cardiovascular (CV) events or graft patency), we assessed two studies as being at low risk of performance or detection bias with good descriptions of the procedures for double‐blinding (<a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a>; <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>). The clinical endpoints (death, CV events) reported in these studies were assessed to recognised standard definitions by staff unaware of allocation. The <a href="./references#CD009971-bbs2-0001" title="AlmeidaR , CoelhoOR , MenesesFH , OliveiraG , MolinariG , FrancaR , et al. The APVS (atorvastatin in the perioperative of vascular surgery) study. Abstract from World Congress of Cardiology Scientific Sessions 2010, Beijing China. Published in Circulation 2010. 2010; Vol. 122 (2):e345. [EMBASE: 70233157] AlmeidaRC , CoelhoOR , MenezesFH , OliveiraGP , MolinariGJPD , FrancaRP , et al. Comparison of effects of high dose (80 mg) atorvastatin versus 20 mg atorvastatin on C‐reactive protein and lipoproteins in patients undergoing major vascular surgery. Abstract from European Society of Cardiolog Congress 2010 Stockholm, Sweden. Published in European Heart Journal. 2010; Vol. 31:64. [EMBASE: 70279734] ">APVS study</a>, which has been reported in only two abstracts, is described as double‐blind but gave no details of how the CV endpoints were assessed. Ramo's study (<a href="./references#CD009971-bbs2-0005" title="RamoOJ , JuhaL , MarttiS , HannuH , PauliinaRM , RistoM . Effects of lovastatin in prevention of restenosis after percutaneous transluminal angioplasty in lower limbs. International Journal of Angiology1995; Vol. 4, issue 4:173‐6. [EMBASE: 1995373334] ">Ramo 1995</a>) of graft patency was assessed as being at high risk of performance and detection bias because the control group received no placebo and there is no mention of blinding. Although repeat angiograms were assessed by radiologists blinded to allocation, the decision to initiate a repeat angiogram before one‐year follow‐up was made by clinicians who knew allocation.The <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a> was also classified as at high risk of performance and detection bias because no description of blinding is provided in the publication. The trial registration on clinicaltrials.gov states that the trial was single‐blind (user). </p> <p>Length of stay was measured in two studies (<a href="./references#CD009971-bbs2-0004" title="RahmanMA , KhanJA , MazariFAK , MockfordK , McCollumPT , ChetterIC . A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Annals of Vascular Surgery2011; Vol. 25, issue 1:32‐8. [EMBASE: 2010702366] ">Rahman 1995</a>; <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>). Both studies were blinded, but we have no details about discharge criteria and who made the decision that participants were fit for discharge. </p> </section> <section id="CD009971-sec-0056"> <h4 class="title">Incomplete outcome data</h4> <p>Two studies gave few details of numbers included in analyses (<a href="./references#CD009971-bbs2-0001" title="AlmeidaR , CoelhoOR , MenesesFH , OliveiraG , MolinariG , FrancaR , et al. The APVS (atorvastatin in the perioperative of vascular surgery) study. Abstract from World Congress of Cardiology Scientific Sessions 2010, Beijing China. Published in Circulation 2010. 2010; Vol. 122 (2):e345. [EMBASE: 70233157] AlmeidaRC , CoelhoOR , MenezesFH , OliveiraGP , MolinariGJPD , FrancaRP , et al. Comparison of effects of high dose (80 mg) atorvastatin versus 20 mg atorvastatin on C‐reactive protein and lipoproteins in patients undergoing major vascular surgery. Abstract from European Society of Cardiolog Congress 2010 Stockholm, Sweden. Published in European Heart Journal. 2010; Vol. 31:64. [EMBASE: 70279734] ">APVS study</a>; <a href="./references#CD009971-bbs2-0004" title="RahmanMA , KhanJA , MazariFAK , MockfordK , McCollumPT , ChetterIC . A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Annals of Vascular Surgery2011; Vol. 25, issue 1:32‐8. [EMBASE: 2010702366] ">Rahman 1995</a>), so completeness of outcome reporting could not be assessed. In two studies, the analyses in published papers included participants who had not undergone surgery and therefore were not eligible for the trial (<a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a>; <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>). Additional correspondence with authors of <a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a> allowed us to establish that participants who had not undergone surgery had not suffered any outcomes. For this study, we decided to exclude these 10 participants who had not undergone surgery from all outcomes except adverse muscle effects. We considered that these were postrandomization exclusions and were not eligible as they had not undergone the surgery that posed the increased risk event. However, they were included for outcomes related to adverse effects of statin therapy. The denominator for the <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a> includes only participants who underwent vascular surgery and about whom we were able to obtain additional information from the authors. </p> </section> <section id="CD009971-sec-0057"> <h4 class="title">Selective reporting</h4> <p>All studies reported the outcomes described in the methods section or the trial register entry if available (<a href="./references#CD009971-bbs2-0001" title="AlmeidaR , CoelhoOR , MenesesFH , OliveiraG , MolinariG , FrancaR , et al. The APVS (atorvastatin in the perioperative of vascular surgery) study. Abstract from World Congress of Cardiology Scientific Sessions 2010, Beijing China. Published in Circulation 2010. 2010; Vol. 122 (2):e345. [EMBASE: 70233157] AlmeidaRC , CoelhoOR , MenezesFH , OliveiraGP , MolinariGJPD , FrancaRP , et al. Comparison of effects of high dose (80 mg) atorvastatin versus 20 mg atorvastatin on C‐reactive protein and lipoproteins in patients undergoing major vascular surgery. Abstract from European Society of Cardiolog Congress 2010 Stockholm, Sweden. Published in European Heart Journal. 2010; Vol. 31:64. [EMBASE: 70279734] ">APVS study</a>; <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>). Preliminary reports from APVS have reported only a combined endpoint (<a href="./references#CD009971-bbs2-0001" title="AlmeidaR , CoelhoOR , MenesesFH , OliveiraG , MolinariG , FrancaR , et al. The APVS (atorvastatin in the perioperative of vascular surgery) study. Abstract from World Congress of Cardiology Scientific Sessions 2010, Beijing China. Published in Circulation 2010. 2010; Vol. 122 (2):e345. [EMBASE: 70233157] AlmeidaRC , CoelhoOR , MenezesFH , OliveiraGP , MolinariGJPD , FrancaRP , et al. Comparison of effects of high dose (80 mg) atorvastatin versus 20 mg atorvastatin on C‐reactive protein and lipoproteins in patients undergoing major vascular surgery. Abstract from European Society of Cardiolog Congress 2010 Stockholm, Sweden. Published in European Heart Journal. 2010; Vol. 31:64. [EMBASE: 70279734] ">APVS study</a>). Although studies reported what they measured, it is notable that only one study measured any participant‐reported outcomes, and only two measured length of stay. </p> </section> <section id="CD009971-sec-0058"> <h4 class="title">Other potential sources of bias</h4> <p><b>Funding sources.</b> Two studies list non‐commercial funding sources (<a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a>; <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>), and three give no information about study funding (<a href="./references#CD009971-bbs2-0001" title="AlmeidaR , CoelhoOR , MenesesFH , OliveiraG , MolinariG , FrancaR , et al. The APVS (atorvastatin in the perioperative of vascular surgery) study. Abstract from World Congress of Cardiology Scientific Sessions 2010, Beijing China. Published in Circulation 2010. 2010; Vol. 122 (2):e345. [EMBASE: 70233157] AlmeidaRC , CoelhoOR , MenezesFH , OliveiraGP , MolinariGJPD , FrancaRP , et al. Comparison of effects of high dose (80 mg) atorvastatin versus 20 mg atorvastatin on C‐reactive protein and lipoproteins in patients undergoing major vascular surgery. Abstract from European Society of Cardiolog Congress 2010 Stockholm, Sweden. Published in European Heart Journal. 2010; Vol. 31:64. [EMBASE: 70279734] ">APVS study</a>; <a href="./references#CD009971-bbs2-0004" title="RahmanMA , KhanJA , MazariFAK , MockfordK , McCollumPT , ChetterIC . A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Annals of Vascular Surgery2011; Vol. 25, issue 1:32‐8. [EMBASE: 2010702366] ">Rahman 1995</a>; <a href="./references#CD009971-bbs2-0005" title="RamoOJ , JuhaL , MarttiS , HannuH , PauliinaRM , RistoM . Effects of lovastatin in prevention of restenosis after percutaneous transluminal angioplasty in lower limbs. International Journal of Angiology1995; Vol. 4, issue 4:173‐6. [EMBASE: 1995373334] ">Ramo 1995</a>). <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a> was funded in part by Pfizer with an unrestricted educational grant. </p> </section> </section> <section id="CD009971-sec-0059"> <h3 class="title" id="CD009971-sec-0059">Effects of interventions</h3> <p>See: <a href="./full#CD009971-tbl-0001"><b>Summary of findings for the main comparison</b> Perioperative statins versus placebo or no treatment for improving outcomes during and after noncardiac vascular surgery</a> </p> <section id="CD009971-sec-0060"> <h4 class="title">Comparison of statin with no treatment/ placebo</h4> <p>Five studies reported the effects of statin compared with placebo (<a href="./references#CD009971-bbs2-0004" title="RahmanMA , KhanJA , MazariFAK , MockfordK , McCollumPT , ChetterIC . A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Annals of Vascular Surgery2011; Vol. 25, issue 1:32‐8. [EMBASE: 2010702366] ">Rahman 1995</a>; <a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a>; <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>), no additional treatment (<a href="./references#CD009971-bbs2-0005" title="RamoOJ , JuhaL , MarttiS , HannuH , PauliinaRM , RistoM . Effects of lovastatin in prevention of restenosis after percutaneous transluminal angioplasty in lower limbs. International Journal of Angiology1995; Vol. 4, issue 4:173‐6. [EMBASE: 1995373334] ">Ramo 1995</a>) or control treatment (<a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a>). </p> </section> <section id="CD009971-sec-0061"> <h4 class="title">Primary outcomes</h4> <p> <ul id="CD009971-list-0014"> <li> <p>All‐cause mortality within 30 days of surgery (<a href="./references#CD009971-fig-0006" title="">Analysis 1.1</a>); was reported in three studies with a total of 178 participants. 7/105 (6.7%) participants in the statin group died within 30 days of surgery, as did 10/73 (13.7%) participants in the control group. No perioperative deaths were reported in the <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a> or the <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a>, and the estimate from <a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a> shows a statistically non‐significant decrease in risk (risk ratio (RR) 0.73, 95% confidence interval (CI) 0.31 to 1.75). Mortality rates were high in this study, approaching 20%, possibly reflecting the poor state of health of participants (<a href="#CD009971-fig-0004">Figure 4</a>). </p> </li> </ul> </p> <div class="figure" id="CD009971-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Statin versus placebo / no treatment, outcome: 1.2 All‐cause mortality." data-id="CD009971-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Statin versus placebo / no treatment, outcome: 1.2 All‐cause mortality. </p> </div> </div> </div> <p> <ul id="CD009971-list-0015"> <li> <p>Death from cardiovascular causes within 30 days of surgery (<a href="./references#CD009971-fig-0007" title="">Analysis 1.2</a>); was reported in three studies but with only two events in one study. Mortality from cardiovascular causes occurred in 1/105 (0.95%) participants receiving statins and 1/73 (1.4%) control participants. The estimate from <a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a> is not informative because confidence intervals were wide (RR 1.05, 95% CI 0.07 to 16.20). </p> </li> </ul> <ul id="CD009971-list-0016"> <li> <p>Nonfatal cardiac events within 30 days of surgery: No studies reported cardiac arrest outcomes. Only one study reported the occurrence of two cases of myocardial necrosis in the AA group based on a troponin rise to above the 99th percentile, but these cases did not meet criteria for MI (<a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>). Non‐fatal MI within 30 days of surgery was reported in three studies and occurred in 4/105 (3.8%) participants in the statin group and 8/73 (11.0%) participants receiving placebo (RR 0.47, 95% CI 0.15 to 1.52) (<a href="#CD009971-fig-0005">Figure 5</a>). </p> </li> </ul> </p> <div class="figure" id="CD009971-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Statin versus placebo/no treatment, outcome: 1.4 Myocardial infarction (non‐fatal)." data-id="CD009971-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Statin versus placebo/no treatment, outcome: 1.4 Myocardial infarction (non‐fatal). </p> </div> </div> </div> </section> <section id="CD009971-sec-0062"> <h4 class="title">Secondary outcomes</h4> <p> <ul id="CD009971-list-0017"> <li> <p>Non‐fatal stroke/TIA (<a href="./references#CD009971-fig-0009" title="">Analysis 1.4</a>); Stroke events were rare, with only two events reported and no statistically significant difference between intervention and placebo groups (RR 0.24, 95% CI 0.03 to 2.25). </p> </li> </ul> <ul id="CD009971-list-0018"> <li> <p>Acute atrial fibrillation (<a href="./references#CD009971-fig-0010" title="">Analysis 1.5</a>): The <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a> reported that 2/22 (9.1%) participants receiving statins developed new atrial fibrillation within seven days of surgery compared with 0/8. This is a much higher reported incidence than that reported in the <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a>, which may reflect differences in detection (Holter used in the <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>) (pooled RR 1.73, 95% CI 0.20 to 14.84). </p> </li> </ul> <ul id="CD009971-list-0019"> <li> <p>Acute kidney injury: No studies reported this outcome.</p> </li> </ul> <ul id="CD009971-list-0020"> <li> <p>Participant‐reported outcomes: Only one study described participant‐reported outcomes in unpublished data. In the <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>, 3/16 participants in the group－1/7 in the PA group and 2/8 in the PP group－reported nausea. The differences were not <i>s</i>tatistically significant. </p> </li> </ul> <ul id="CD009971-list-0021"> <li> <p>Graft patency (<a href="./references#CD009971-fig-0012" title="">Analysis 1.7</a>): One small study reported this outcome with a non‐significant reduction in restenosis after lower limb arterial angioplasty; 4/18 (22%) participants receiving statins and aspirin required repeat angioplasty within one year compared with 8<b>/</b>19 (42%) in the control group receiving aspirin only (RR 0.53, 95% CI 0.19 to 1.45) (<a href="./references#CD009971-bbs2-0005" title="RamoOJ , JuhaL , MarttiS , HannuH , PauliinaRM , RistoM . Effects of lovastatin in prevention of restenosis after percutaneous transluminal angioplasty in lower limbs. International Journal of Angiology1995; Vol. 4, issue 4:173‐6. [EMBASE: 1995373334] ">Ramo 1995</a>). Two participants in the statin group and four in the aspirin only group required amputation during follow‐up. In the <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>, one participant who had received statins before peripheral vascular disease (PVD) required toe amputation, although the graft remained patent. </p> </li> </ul> <ul id="CD009971-list-0022"> <li> <p>Length of stay: Length of stay was reported in Rahman's study of open AAA repair (<a href="./references#CD009971-bbs2-0004" title="RahmanMA , KhanJA , MazariFAK , MockfordK , McCollumPT , ChetterIC . A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Annals of Vascular Surgery2011; Vol. 25, issue 1:32‐8. [EMBASE: 2010702366] ">Rahman 1995</a>) and in the <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a> (<a href="./references#CD009971-fig-0011" title="">Analysis 1.6</a>). No statistically significant differences in total hospital stay or stay in the high‐dependency unit were noted between statin and placebo groups. </p> </li> </ul> <ul id="CD009971-list-0023"> <li> <p>Clinical muscle syndromes (<a href="./references#CD009971-fig-0013" title="">Analysis 1.8</a>): Several studies reported muscle enzyme levels as a safety measure, but only three (with a total of 188 participants) reported explicitly on clinical syndromes, with seven events reported. No statistically significant differences were noted between statin and placebo groups. Given differences in the ascertainment and definition of outcome, we decided not to pool these estimates. </p> </li> </ul> </p> </section> <section id="CD009971-sec-0063"> <h4 class="title">Comparison of high‐dose with low‐dose statin</h4> <p>Only two studies compared outcomes in participants who had received high‐ and low‐dose statin. The <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a> reported all outcomes, but only one MI was reported in the low‐dose (A10) group and one new atrial fibrillation in the high‐dose (A80) group. In preliminary reports from the <a href="./references#CD009971-bbs2-0001" title="AlmeidaR , CoelhoOR , MenesesFH , OliveiraG , MolinariG , FrancaR , et al. The APVS (atorvastatin in the perioperative of vascular surgery) study. Abstract from World Congress of Cardiology Scientific Sessions 2010, Beijing China. Published in Circulation 2010. 2010; Vol. 122 (2):e345. [EMBASE: 70233157] AlmeidaRC , CoelhoOR , MenezesFH , OliveiraGP , MolinariGJPD , FrancaRP , et al. Comparison of effects of high dose (80 mg) atorvastatin versus 20 mg atorvastatin on C‐reactive protein and lipoproteins in patients undergoing major vascular surgery. Abstract from European Society of Cardiolog Congress 2010 Stockholm, Sweden. Published in European Heart Journal. 2010; Vol. 31:64. [EMBASE: 70279734] ">APVS study</a>, only combined cardiovascular endpoints (cardiac death, non‐fatal MI and stroke) were reported with 3/53 (5.7% incidence) in the A80 group and 7/53 (13.2%) in the A20 group. This gives a relative risk of 0.43 (95% CI 0.12 to 1.57). We do not have sufficient data to present effect estimates on any of our prespecified outcomes for this comparison. </p> </section> <section id="CD009971-sec-0064"> <h4 class="title">Sensitivity analyses</h4> <p>We were unable to carry out planned sensitivity analyses on type of intervention, elective or emergency surgery or duration of statin use because of low numbers of studies. The <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a> had a shorter duration of statin use than other studies and had a non‐significant increase in MI among statin users, but no significant heterogeneity was noted between study results. </p> <p>We excluded the <a href="./references#CD009971-bbs2-0010" title="PoldermansD . Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery: results from a randomized placebo controlled trial: DECREASE III. European Society of Cardiology Congress; August 2008; Munich, Germany. [CN‐00713534] PoldermansD . Statins and noncardiac surgery: current evidence and practical considerations. Cleveland Clinic Journal of Medicine2009; Vol. (76 Suppl 4):S79‐83. [PUBMED: 19880840] PoldermansD , SchoutenO , BaxJ , WinkelTA . Reducing cardiac risk in non‐cardiac surgery: evidence from the DECREASE studies. European Heart Journal Supplements2009; Vol. 11, issue A:A9‐A14. [WOS:000265835900003] SchoutenO , BoersmaE , HoeksSE , BennerR , VanUrkH , VanSambeekMRHM , et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. New England Journal of Medicine2009; Vol. 361, issue 10:980‐9. [EMBASE: 2009479335] SchoutenO , HoeksSE , BoersmaH , VouteMT , RavensbergenN , Bastos GoncalvesF , et al. Long‐term outcome of the DECREASE III trial; the impact of initiation of statin therapy prior to surgery. Abstract from European Society of Cardiology Congress, 2011, Paris France. Published in European Heart Journal. 2011; Vol. 32:332‐3. [EMBASE: 70534292] SchoutenO , HoeksSE , PoldermansD . Fluvastatin in patients undergoing vascular surgery (REPLY). New England Journal of Medicine2009; Vol. 361, issue 22:2187‐8. [WOS:000272117800018] SchoutenO , HoeksSE , VouteMT , BoersmaE , VerhagenHJ , PoldermansD . Long‐term benefit of perioperative statin use in patients undergoing vascular surgery: Results from the DECREASE III trial. Abstract from Vascular Annual Meeting of the Society for Vascular Surgery, 2011, Chicago, IL United States. Published in Journal of Vascular Surgery. 2011; Vol. 53 (6 SUPPL. 1):20S‐1S. [EMBASE: 70435717] SchoutenO , HoeksSE , VouteMT , RavensbergenN , Van DeLuijtgaardenK , Bastos GoncalvesF , et al. Perioperative myocardial ischemia: A preventable cause of poor long‐term outcome after vascular surgery?. Abstract from European Society of Cardiology Congress, 2011, Paris, France. Published in European Heart Journal. 2011; Vol. 32:556. [EMBASE: 70535145] SchoutenO , PoldermansD , VisserL , KertaiMD , KleinJ , vanUrkH , et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high‐risk patients undergoing non‐cardiac surgery: rationale and design of the DECREASE‐IV study. American Heart Journal2004; Vol. 148, issue 6:1047‐52. [WOS:000225970400021] SchoutenO , VerhagenHJ , PoldermansD . Endovascular repair of abdominal aortic aneurysm. New England Journal of Medicine2010; Vol. 363, issue 15:1480‐1; author reply 1481‐2. [EMBASE: 20931722] ">DECREASE III</a> study because of concerns about validity, but we ran sensitivity analyses on its impact on our results for comparison 1－statin versus placebo/no treatment. This trial consisted of 497 participants who were scheduled for AAA repair, distal aorto‐iliac reconstruction, lower limb arterial reconstruction or carotid endarterectomy at Erasmus Medical Centre, Rotterdam, Netherlands. In these analyses, our achieved sample size was 356 in the statin group and 320 in the control group. Results from DECREASE were similar to those of included studies, and in these analyses, the pooled estimates were as follows: for all‐cause mortality, RR 0.61 (95% CI, 0.32 to 1.17); for death from cardiovascular causes, RR 0.56 (95% CI, 0.19 to 1.65); for MI, RR 0.47 (95% CI, 0.24 to 0.92); and for stroke, RR 0.34 (95% CI, 0.07 to 1.72). No clinical muscle syndrome events were reported in <a href="./references#CD009971-bbs2-0010" title="PoldermansD . Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery: results from a randomized placebo controlled trial: DECREASE III. European Society of Cardiology Congress; August 2008; Munich, Germany. [CN‐00713534] PoldermansD . Statins and noncardiac surgery: current evidence and practical considerations. Cleveland Clinic Journal of Medicine2009; Vol. (76 Suppl 4):S79‐83. [PUBMED: 19880840] PoldermansD , SchoutenO , BaxJ , WinkelTA . Reducing cardiac risk in non‐cardiac surgery: evidence from the DECREASE studies. European Heart Journal Supplements2009; Vol. 11, issue A:A9‐A14. [WOS:000265835900003] SchoutenO , BoersmaE , HoeksSE , BennerR , VanUrkH , VanSambeekMRHM , et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. New England Journal of Medicine2009; Vol. 361, issue 10:980‐9. [EMBASE: 2009479335] SchoutenO , HoeksSE , BoersmaH , VouteMT , RavensbergenN , Bastos GoncalvesF , et al. Long‐term outcome of the DECREASE III trial; the impact of initiation of statin therapy prior to surgery. Abstract from European Society of Cardiology Congress, 2011, Paris France. Published in European Heart Journal. 2011; Vol. 32:332‐3. [EMBASE: 70534292] SchoutenO , HoeksSE , PoldermansD . Fluvastatin in patients undergoing vascular surgery (REPLY). New England Journal of Medicine2009; Vol. 361, issue 22:2187‐8. [WOS:000272117800018] SchoutenO , HoeksSE , VouteMT , BoersmaE , VerhagenHJ , PoldermansD . Long‐term benefit of perioperative statin use in patients undergoing vascular surgery: Results from the DECREASE III trial. Abstract from Vascular Annual Meeting of the Society for Vascular Surgery, 2011, Chicago, IL United States. Published in Journal of Vascular Surgery. 2011; Vol. 53 (6 SUPPL. 1):20S‐1S. [EMBASE: 70435717] SchoutenO , HoeksSE , VouteMT , RavensbergenN , Van DeLuijtgaardenK , Bastos GoncalvesF , et al. Perioperative myocardial ischemia: A preventable cause of poor long‐term outcome after vascular surgery?. Abstract from European Society of Cardiology Congress, 2011, Paris, France. Published in European Heart Journal. 2011; Vol. 32:556. [EMBASE: 70535145] SchoutenO , PoldermansD , VisserL , KertaiMD , KleinJ , vanUrkH , et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high‐risk patients undergoing non‐cardiac surgery: rationale and design of the DECREASE‐IV study. American Heart Journal2004; Vol. 148, issue 6:1047‐52. [WOS:000225970400021] SchoutenO , VerhagenHJ , PoldermansD . Endovascular repair of abdominal aortic aneurysm. New England Journal of Medicine2010; Vol. 363, issue 15:1480‐1; author reply 1481‐2. [EMBASE: 20931722] ">DECREASE III</a>. Inclusion of these data would have led to a statistically significant pooled result for MI reduction in statin users but otherwise would not have altered results. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009971-sec-0065" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009971-sec-0065"></div> <section id="CD009971-sec-0066"> <h3 class="title" id="CD009971-sec-0066">Summary of main results</h3> <p>Our review has found no evidence that perioperative administration of statins has a beneficial effect on the outcome of patients undergoing vascular surgery. Our results for all outcomes are consistent with increased and decreased risk of cardiovascular events in the 30 days after surgery. For some of our primary outcomes (all‐cause mortality and non‐fatal MI), the included studies show a decrease in risk of approximately 50% in the group treated with statins, but because of low numbers of events, the difference in risk between participant groups did not reach statistical significance. For a control population with a 4% risk of MI, this means that participants treated with statins could have a risk of 0.6% to 6.1% (<a href="./full#CD009971-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>The risk of clinical muscle syndromes was low in these study populations with only 5/111 events in statin users and 2/77 in the control group across all studies. We were focusing on clinical symptoms rather than enzyme levels, and variations in the incidence of muscle effects indicate that there may have been differences in ascertainment across studies with 1/100 cases in <a href="./references#CD009971-bbs2-0002" title="CaramelliB , CalderaroD , YuPC , GualandroD . Preoperative lipid‐lowering therapy on postoperative outcome. American Journal of Cardiology2007; Vol. 100, issue 7:1185. [PUBMED: 17884389] CaramelliB , DurazzoA , IkeokaD , DeBernocheC , MonachiniM , Puech‐LeaoP , et al. Short‐term treatment with atorvastatin for prevention of cardiac complications after vascular surgery [abstract no:086]. Atherosclerosis Supplements2002, issue 2:83. [CENTRAL: CN‐00784215] DurazzoAEDS , MachadoFS , IkeokaDT , DeBernocheC , MonachiniMC , Puech‐LeaoP , et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery2004; Vol. 39, issue 5:967‐76. [EMBASE: 2004198566] DurazzoAES , MachadoFS , IkeokaD , Puech‐LeaoP , CaramelliB . Effect of atorvastatin on cardiovascular events after vascular surgery. Circulation2002, issue 19 Suppl:II‐343. [CENTRAL: CN‐00520506] ">Durazzo 2004</a> but 6/30 in the <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>, so we decided not to present a pooled estimate of effect. However overall, it would appear that adverse clinical muscle syndromes were unusual in the perioperative period. This is confirmed by observational data from vascular surgery participants with estimates of rhabdomyolysis incidence of between 0.1% and 0.5% and no clear evidence that statins increase the risk of postoperative muscle syndromes (<a href="./references#CD009971-bbs2-0036" title="BiccardBM . A peri‐operative statin update for non‐cardiac surgery. Part II: Statin therapy for vascular surgery and peri‐operative statin trial design. Anaesthesia2008;63(2):162‐71. [PUBMED: 18211448] ">Biccard 2008</a>; <a href="./references#CD009971-bbs2-0037" title="BiccardBM . Investigation of predictors of increased creatine kinase levels following vascular surgery and the association with peri‐operative statin therapy. Cardiovascular Journal of Africa2009;20(3):187‐91. [PUBMED: 19575084] ">Biccard 2009</a>). In one observational study, statin use decreased the risk of elevated creatinine kinase after vascular surgery (<a href="./references#CD009971-bbs2-0037" title="BiccardBM . Investigation of predictors of increased creatine kinase levels following vascular surgery and the association with peri‐operative statin therapy. Cardiovascular Journal of Africa2009;20(3):187‐91. [PUBMED: 19575084] ">Biccard 2009</a>). </p> <p>Only two studies－one with only preliminary data (<a href="./references#CD009971-bbs2-0001" title="AlmeidaR , CoelhoOR , MenesesFH , OliveiraG , MolinariG , FrancaR , et al. The APVS (atorvastatin in the perioperative of vascular surgery) study. Abstract from World Congress of Cardiology Scientific Sessions 2010, Beijing China. Published in Circulation 2010. 2010; Vol. 122 (2):e345. [EMBASE: 70233157] AlmeidaRC , CoelhoOR , MenezesFH , OliveiraGP , MolinariGJPD , FrancaRP , et al. Comparison of effects of high dose (80 mg) atorvastatin versus 20 mg atorvastatin on C‐reactive protein and lipoproteins in patients undergoing major vascular surgery. Abstract from European Society of Cardiolog Congress 2010 Stockholm, Sweden. Published in European Heart Journal. 2010; Vol. 31:64. [EMBASE: 70279734] ">APVS study</a>; <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a>)－have investigated the influence of dose of statin on outcomes, and we could not present an effect estimate for any of our outcomes. We found a non‐significantly decreased risk of a combined cardiovascular endpoint in the group receiving the higher statin dose. </p> </section> <section id="CD009971-sec-0067"> <h3 class="title" id="CD009971-sec-0067">Overall completeness and applicability of evidence</h3> <p>Despite a comprehensive search strategy and review of 5804 titles, evidence for our outcomes is sparse. Exclusion of the largest available study (<a href="./references#CD009971-bbs2-0010" title="PoldermansD . Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery: results from a randomized placebo controlled trial: DECREASE III. European Society of Cardiology Congress; August 2008; Munich, Germany. [CN‐00713534] PoldermansD . Statins and noncardiac surgery: current evidence and practical considerations. Cleveland Clinic Journal of Medicine2009; Vol. (76 Suppl 4):S79‐83. [PUBMED: 19880840] PoldermansD , SchoutenO , BaxJ , WinkelTA . Reducing cardiac risk in non‐cardiac surgery: evidence from the DECREASE studies. European Heart Journal Supplements2009; Vol. 11, issue A:A9‐A14. [WOS:000265835900003] SchoutenO , BoersmaE , HoeksSE , BennerR , VanUrkH , VanSambeekMRHM , et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. New England Journal of Medicine2009; Vol. 361, issue 10:980‐9. [EMBASE: 2009479335] SchoutenO , HoeksSE , BoersmaH , VouteMT , RavensbergenN , Bastos GoncalvesF , et al. Long‐term outcome of the DECREASE III trial; the impact of initiation of statin therapy prior to surgery. Abstract from European Society of Cardiology Congress, 2011, Paris France. Published in European Heart Journal. 2011; Vol. 32:332‐3. [EMBASE: 70534292] SchoutenO , HoeksSE , PoldermansD . Fluvastatin in patients undergoing vascular surgery (REPLY). New England Journal of Medicine2009; Vol. 361, issue 22:2187‐8. [WOS:000272117800018] SchoutenO , HoeksSE , VouteMT , BoersmaE , VerhagenHJ , PoldermansD . Long‐term benefit of perioperative statin use in patients undergoing vascular surgery: Results from the DECREASE III trial. Abstract from Vascular Annual Meeting of the Society for Vascular Surgery, 2011, Chicago, IL United States. Published in Journal of Vascular Surgery. 2011; Vol. 53 (6 SUPPL. 1):20S‐1S. [EMBASE: 70435717] SchoutenO , HoeksSE , VouteMT , RavensbergenN , Van DeLuijtgaardenK , Bastos GoncalvesF , et al. Perioperative myocardial ischemia: A preventable cause of poor long‐term outcome after vascular surgery?. Abstract from European Society of Cardiology Congress, 2011, Paris, France. Published in European Heart Journal. 2011; Vol. 32:556. [EMBASE: 70535145] SchoutenO , PoldermansD , VisserL , KertaiMD , KleinJ , vanUrkH , et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high‐risk patients undergoing non‐cardiac surgery: rationale and design of the DECREASE‐IV study. American Heart Journal2004; Vol. 148, issue 6:1047‐52. [WOS:000225970400021] SchoutenO , VerhagenHJ , PoldermansD . Endovascular repair of abdominal aortic aneurysm. New England Journal of Medicine2010; Vol. 363, issue 15:1480‐1; author reply 1481‐2. [EMBASE: 20931722] ">DECREASE III</a>) has severely restricted the power of the review. Power calculations indicate that to detect a 50% reduction in MI incidence from 4% to 2% with 80% power and 5% significance would require inclusion of 1141 participants in each group. Our sample size was less than 10% of this. Two additional studies included had small samples and few events (<a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a>; <a href="./references#CD009971-bbs2-0006" title="NeilipovitzDT , BrysonGL , TaljaardM . STAR VaS－Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo‐controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Canadian Journal of Anaesthesia2012; Vol. 59, issue 6:527‐37. [PUBMED: 22528165] ">STAR VaS study</a>). Six remaining studies appear to have the correct design and intervention but with no available outcome data, and it is possible that these studies may show different effects. However, all of these studies are small, and there are concerns about the quality of data on outcomes that were not prespecified for the trial. </p> <p>It is striking that only one study reported on participant‐reported outcomes; this shows an important deficit in the literature. </p> </section> <section id="CD009971-sec-0068"> <h3 class="title" id="CD009971-sec-0068">Quality of the evidence</h3> <p>The included studies were well designed and executed. Based on the study publications, we had serious concerns about potential detection bias in only two studies, in which clinicians were not blinded (<a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a>; <a href="./references#CD009971-bbs2-0005" title="RamoOJ , JuhaL , MarttiS , HannuH , PauliinaRM , RistoM . Effects of lovastatin in prevention of restenosis after percutaneous transluminal angioplasty in lower limbs. International Journal of Angiology1995; Vol. 4, issue 4:173‐6. [EMBASE: 1995373334] ">Ramo 1995)</a>. Including the <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a> data is somewhat problematic as the outcome data collection was not planned and may not be of high quality. However, given the small numbers of events in this study, sensitivity analyses removing it had only a minor effect on effect size and confidence intervals.The <a href="./references#CD009971-bbs2-0003" title="PuatoM , ElisabettaF , RattazziM , CipolloneF , ZambonA , GregoF , et al. Atorvastatin reduces macrophage accumulation in the atherosclerotic plaque in patients undergoing carotid endarterectomy: a comparison versus non‐statin based regimen. Abstract from 78th European Atherosclerosis Society Congress, Hamburg Germany. Published in Atherosclerosis Supplements. 2010; Vol. 11 (2):23. [EMBASE: 70201591] PuatoM , FagginE , RattazziM , ZambonA , CipolloneF , GregoF , et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin‐based regimen in patients undergoing carotid endarterectomy. Stroke2010; Vol. 41, issue 6:1163‐8. [EMBASE: 2010315441] ">MAPS study</a> had received commercial funding but stated that this work was supported by an unrestricted educational grant. </p> <p>The most serious concern about the quality of the evidence concerned <a href="./references#CD009971-bbs2-0010" title="PoldermansD . Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery: results from a randomized placebo controlled trial: DECREASE III. European Society of Cardiology Congress; August 2008; Munich, Germany. [CN‐00713534] PoldermansD . Statins and noncardiac surgery: current evidence and practical considerations. Cleveland Clinic Journal of Medicine2009; Vol. (76 Suppl 4):S79‐83. [PUBMED: 19880840] PoldermansD , SchoutenO , BaxJ , WinkelTA . Reducing cardiac risk in non‐cardiac surgery: evidence from the DECREASE studies. European Heart Journal Supplements2009; Vol. 11, issue A:A9‐A14. [WOS:000265835900003] SchoutenO , BoersmaE , HoeksSE , BennerR , VanUrkH , VanSambeekMRHM , et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. New England Journal of Medicine2009; Vol. 361, issue 10:980‐9. [EMBASE: 2009479335] SchoutenO , HoeksSE , BoersmaH , VouteMT , RavensbergenN , Bastos GoncalvesF , et al. Long‐term outcome of the DECREASE III trial; the impact of initiation of statin therapy prior to surgery. Abstract from European Society of Cardiology Congress, 2011, Paris France. Published in European Heart Journal. 2011; Vol. 32:332‐3. [EMBASE: 70534292] SchoutenO , HoeksSE , PoldermansD . Fluvastatin in patients undergoing vascular surgery (REPLY). New England Journal of Medicine2009; Vol. 361, issue 22:2187‐8. [WOS:000272117800018] SchoutenO , HoeksSE , VouteMT , BoersmaE , VerhagenHJ , PoldermansD . Long‐term benefit of perioperative statin use in patients undergoing vascular surgery: Results from the DECREASE III trial. Abstract from Vascular Annual Meeting of the Society for Vascular Surgery, 2011, Chicago, IL United States. Published in Journal of Vascular Surgery. 2011; Vol. 53 (6 SUPPL. 1):20S‐1S. [EMBASE: 70435717] SchoutenO , HoeksSE , VouteMT , RavensbergenN , Van DeLuijtgaardenK , Bastos GoncalvesF , et al. Perioperative myocardial ischemia: A preventable cause of poor long‐term outcome after vascular surgery?. Abstract from European Society of Cardiology Congress, 2011, Paris, France. Published in European Heart Journal. 2011; Vol. 32:556. [EMBASE: 70535145] SchoutenO , PoldermansD , VisserL , KertaiMD , KleinJ , vanUrkH , et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high‐risk patients undergoing non‐cardiac surgery: rationale and design of the DECREASE‐IV study. American Heart Journal2004; Vol. 148, issue 6:1047‐52. [WOS:000225970400021] SchoutenO , VerhagenHJ , PoldermansD . Endovascular repair of abdominal aortic aneurysm. New England Journal of Medicine2010; Vol. 363, issue 15:1480‐1; author reply 1481‐2. [EMBASE: 20931722] ">DECREASE III</a>, for which the authors were investigated about consent obtained and whether study results can be related to participant data. These papers have not been withdrawn, but we decided to exclude them from the review. </p> </section> <section id="CD009971-sec-0069"> <h3 class="title" id="CD009971-sec-0069">Potential biases in the review process</h3> <p>We were unable to undertake funnel plots or to assess publication bias because we identified fewer than 10 studies for any outcome. </p> </section> <section id="CD009971-sec-0070"> <h3 class="title" id="CD009971-sec-0070">Agreements and disagreements with other studies or reviews</h3> <p>Existing reviews of RCTs have considered all types of noncardiac surgery as a single group and were not restricted to vascular surgery participants. This increased the size and the number of trials. All reviews conclude that statins significantly reduce the incidence of CV events with relative risk for postoperative MI and all‐cause mortality reported as 0.52 (95% CI 0.36 to 0.74) and 0.59 (95% CI 0.31 to1.12), respectively, in <a href="./references#CD009971-bbs2-0039" title="ChopraV , WesorickDH , SussmanJB , GreeneT , RogersM , FroehlichJB , et al. Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta‐analysis. Archives of Surgery2012; Vol. 147, issue 2:181‐9. [PUBMED: 22351917] ">Chopra 2012</a> and as 0.57 (95% CI 0.46 to 0.70) and 0.61 (95% CI 0.37 to 1.17) in <a href="./references#CD009971-bbs2-0074" title="WinchesterDE , WenX , XieL , BavryAA . Evidence of pre‐procedural statin therapy a meta‐analysis of randomized trials. Journal of the American College of Cardiology2010; Vol. 56, issue 14:1099‐109. [PUBMED: 20825761] ">Winchester 2010</a>. There is considerable, but not complete, overlap between the studies included in this review and in previous reviews. <a href="./references#CD009971-bbs2-0010" title="PoldermansD . Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery: results from a randomized placebo controlled trial: DECREASE III. European Society of Cardiology Congress; August 2008; Munich, Germany. [CN‐00713534] PoldermansD . Statins and noncardiac surgery: current evidence and practical considerations. Cleveland Clinic Journal of Medicine2009; Vol. (76 Suppl 4):S79‐83. [PUBMED: 19880840] PoldermansD , SchoutenO , BaxJ , WinkelTA . Reducing cardiac risk in non‐cardiac surgery: evidence from the DECREASE studies. European Heart Journal Supplements2009; Vol. 11, issue A:A9‐A14. [WOS:000265835900003] SchoutenO , BoersmaE , HoeksSE , BennerR , VanUrkH , VanSambeekMRHM , et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. New England Journal of Medicine2009; Vol. 361, issue 10:980‐9. [EMBASE: 2009479335] SchoutenO , HoeksSE , BoersmaH , VouteMT , RavensbergenN , Bastos GoncalvesF , et al. Long‐term outcome of the DECREASE III trial; the impact of initiation of statin therapy prior to surgery. Abstract from European Society of Cardiology Congress, 2011, Paris France. Published in European Heart Journal. 2011; Vol. 32:332‐3. [EMBASE: 70534292] SchoutenO , HoeksSE , PoldermansD . Fluvastatin in patients undergoing vascular surgery (REPLY). New England Journal of Medicine2009; Vol. 361, issue 22:2187‐8. [WOS:000272117800018] SchoutenO , HoeksSE , VouteMT , BoersmaE , VerhagenHJ , PoldermansD . Long‐term benefit of perioperative statin use in patients undergoing vascular surgery: Results from the DECREASE III trial. Abstract from Vascular Annual Meeting of the Society for Vascular Surgery, 2011, Chicago, IL United States. Published in Journal of Vascular Surgery. 2011; Vol. 53 (6 SUPPL. 1):20S‐1S. [EMBASE: 70435717] SchoutenO , HoeksSE , VouteMT , RavensbergenN , Van DeLuijtgaardenK , Bastos GoncalvesF , et al. Perioperative myocardial ischemia: A preventable cause of poor long‐term outcome after vascular surgery?. Abstract from European Society of Cardiology Congress, 2011, Paris, France. Published in European Heart Journal. 2011; Vol. 32:556. [EMBASE: 70535145] SchoutenO , PoldermansD , VisserL , KertaiMD , KleinJ , vanUrkH , et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high‐risk patients undergoing non‐cardiac surgery: rationale and design of the DECREASE‐IV study. American Heart Journal2004; Vol. 148, issue 6:1047‐52. [WOS:000225970400021] SchoutenO , VerhagenHJ , PoldermansD . Endovascular repair of abdominal aortic aneurysm. New England Journal of Medicine2010; Vol. 363, issue 15:1480‐1; author reply 1481‐2. [EMBASE: 20931722] ">DECREASE III</a> is important in other published estimates. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009971-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/urn:x-wiley:14651858:media:CD009971:CD009971-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_t/tCD009971-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Sudy flow diagram." data-id="CD009971-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Sudy flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009971-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/urn:x-wiley:14651858:media:CD009971:CD009971-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_t/tCD009971-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009971-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009971-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/urn:x-wiley:14651858:media:CD009971:CD009971-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_t/tCD009971-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009971-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009971-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/urn:x-wiley:14651858:media:CD009971:CD009971-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_t/tCD009971-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Statin versus placebo / no treatment, outcome: 1.2 All‐cause mortality." data-id="CD009971-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Statin versus placebo / no treatment, outcome: 1.2 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009971-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/urn:x-wiley:14651858:media:CD009971:CD009971-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_t/tCD009971-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Statin versus placebo/no treatment, outcome: 1.4 Myocardial infarction (non‐fatal)." data-id="CD009971-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Statin versus placebo/no treatment, outcome: 1.4 Myocardial infarction (non‐fatal). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009971-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/urn:x-wiley:14651858:media:CD009971:CD009971-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_t/tCD009971-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Statin versus placebo / no treatment, Outcome 1 All‐cause mortality." data-id="CD009971-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Statin versus placebo / no treatment, Outcome 1 All‐cause mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/references#CD009971-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009971-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/urn:x-wiley:14651858:media:CD009971:CD009971-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_t/tCD009971-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Statin versus placebo / no treatment, Outcome 2 Death from cardiovascular causes." data-id="CD009971-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Statin versus placebo / no treatment, Outcome 2 Death from cardiovascular causes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/references#CD009971-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009971-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/urn:x-wiley:14651858:media:CD009971:CD009971-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_t/tCD009971-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Statin versus placebo / no treatment, Outcome 3 Myocardial infarction (non‐fatal)." data-id="CD009971-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Statin versus placebo / no treatment, Outcome 3 Myocardial infarction (non‐fatal). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/references#CD009971-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009971-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/urn:x-wiley:14651858:media:CD009971:CD009971-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_t/tCD009971-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Statin versus placebo / no treatment, Outcome 4 Stroke or TIA (non‐fatal)." data-id="CD009971-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Statin versus placebo / no treatment, Outcome 4 Stroke or TIA (non‐fatal).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/references#CD009971-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009971-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/urn:x-wiley:14651858:media:CD009971:CD009971-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_t/tCD009971-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Statin versus placebo / no treatment, Outcome 5 New atrial fibrillation." data-id="CD009971-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Statin versus placebo / no treatment, Outcome 5 New atrial fibrillation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/references#CD009971-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009971-fig-0011"> <p> <div class="table" id="CD009971-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Hospital stay. Days‐ median (IQR/range )</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>High dependency unit stay Days ‐ median (IQR)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rahman 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Atorvastatin group N=20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7 (5‐47)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (1‐6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rahman 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo group N=20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 (5‐25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 (1‐6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rahman 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significance test (Mann‐Whitney U test)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>p=0.869</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>p=0.756</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>STAR VaS study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AA group N = 15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 (5‐8) (mean 9.07 SD= 9.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>STAR VaS study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PA group N=7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 (4‐7) (mean 6.00 SD =1.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>STAR VaS study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PP group N=8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 (4.5‐7) ( mean 6.75 SD = 4.50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Statin versus placebo / no treatment, Outcome 6 Length of stay.</p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/references#CD009971-fig-0011">Navigate to figure in review</a></div> </div> <div class="figure" id="CD009971-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/urn:x-wiley:14651858:media:CD009971:CD009971-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_t/tCD009971-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Statin versus placebo / no treatment, Outcome 7 Graft patency." data-id="CD009971-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Statin versus placebo / no treatment, Outcome 7 Graft patency.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/references#CD009971-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009971-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/urn:x-wiley:14651858:media:CD009971:CD009971-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_t/tCD009971-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Statin versus placebo / no treatment, Outcome 8 Clinical muscle syndromes." data-id="CD009971-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Statin versus placebo / no treatment, Outcome 8 Clinical muscle syndromes.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/references#CD009971-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/media/CDSR/CD009971/image_n/nCD009971-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009971-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Perioperative statins versus placebo or no treatment for improving outcomes during and after noncardiac vascular surgery</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Perioperative statins versus placebo or no treatment for improving outcomes during and after noncardiac vascular surgery</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> participants with improving outcomes during and after noncardiac vascular surgery.<br/> <b>Settings:</b> hospital.<br/> <b>Intervention:</b> perioperative statins versus placebo or no treatment. </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Perioperative statins versus placebo or no treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b> <br/> Follow‐up: 30 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.73</b> <br/> (0.31 to 1.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>178<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Effect estimate based on 1 study only.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 1000</b> <br/> (12 to 70) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Death from cardiovascular causes</b> <br/> Follow‐up: 30 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.05</b> <br/> (0.07 to 16.2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>178<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Effect estimate based on 2 events occurring in 1 study.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b> <br/> (2 to 486) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Myocardial infarction (non‐fatal)</b> <br/> Follow‐up: 30 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.47</b> <br/> (0.15 to 1.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>178<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> <br/> (6 to 61) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Stroke/TIA (non‐fatal)</b> <br/> Follow‐up: 30 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.24</b> <br/> (0.03 to 2.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>178<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Two events only across 3 studies.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>2 per 1000</b> <br/> (0 to 22) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported outcomes</b>－not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only 1 study measured or reported any participant‐reported outcomes (nausea in STAR VaS). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse muscle effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>188<br/> (3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to pool. Important differences in assessment of endpoint between studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence:<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect;<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate;<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate; and<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Based on observational data reported by <a href="./references#CD009971-bbs2-0062" title="NowygrodR , EgorovaN , GrecoG , AndersonP , GelijnsA , MoskowitzA , et al. Trends, complications, and mortality in peripheral vascular surgery. Journal of Vascular Surgery2006; Vol. 43, issue 2:205‐16. [PUBMED: 16476588] ">Nowygrod 2006</a> and <a href="./references#CD009971-bbs2-0054" title="LeManachY , Ibanez EstevesC , BertrandM , GoarinJP , FleronMH , CoriatP , et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery. Anesthesiology2011; Vol. 114, issue 1:98‐104. [PUBMED: 21178671] ">Le Manach 2011</a>.<br/> <sup>2</sup> Confidence interval crosses no effect and is consistent with increased and decreased risks.<br/> <sup>3</sup> Effect estimate from 1 study and/or based on fewer then 5 events. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Perioperative statins versus placebo or no treatment for improving outcomes during and after noncardiac vascular surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/full#CD009971-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009971-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Statin versus placebo / no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.31, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death from cardiovascular causes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.07, 16.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Myocardial infarction (non‐fatal) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.15, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Stroke or TIA (non‐fatal) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.03, 2.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 New atrial fibrillation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.73 [0.20, 14.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Length of stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Graft patency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Restenosis required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.19, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Amputation required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.16, 2.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Clinical muscle syndromes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Statin versus placebo / no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009971.pub2/references#CD009971-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009971.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009971-note-0001">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009971-note-0007">فارسی</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009971\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009971\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009971\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009971\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009971\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009971.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009971.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009971.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009971.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009971.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726512300"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009971.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726512304"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009971.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e95734afbf3c9',t:'MTc0MDcyNjUxMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 